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Abstract 
This thesis focused on nucleobase modified peptide nucleic acid (PNA) and DNA to expand 
the repertoire of available nucleobase analogs used in the study of nucleic acids. More 
specifically, we are interested in modification of the nucleobases such that they retain their 
ability to undergo Watson-Crick base pairing. Moreover, our goal is to modify the 
nucleobases in order to engender them with useful photophysical properties such that they 
may be used as biomolecular tools to investigate nucleic acid structure and dynamics. 
To that end, a derivative of 5-aminouracil (5-AU) labelled with the amine-reactive 
chromophore 9-chloroacridine was prepared for the purpose of investigating its potential as a 
base-discriminating fluorophore. This modified nucleobase was incorporated into PNA by 
fluorenylmethyloxycarbonyl (Fmoc)-based oligomerization chemistry. During study of its 
hybridization to complementary DNA (cDNA), the 5-substitution was found to be thermally 
labile and hydrolyzed to a small degree in neutral aqueous solution, thus liberating the highly 
fluorescent acridone moiety. 
Moreover, three novel fluorescent 7-deaza-2´-deoxyadenosine analogs were successfully 
synthesized via the Sonogashira cross-coupling reaction of 7-iodo-7-deaza-2´-
deoxyadenosine with 1-ethynylpyrene, 2-ethynyl-6-methoxynaphthalene, and 9-
ethynylphenanthrene. These analogs were photophysically characterized in dioxane, EtOH, 
and H2O to evaluate their potential for use as environmentally sensitive fluorescent probes. 
All three analogs displayed high solvatofluorochromicity in H2O, relative to their emission 
wavelengths in dioxane and EtOH. Moreover, all three analogs exhibited moderate to high 
fluorescence quantum yields in dioxane and EtOH, and significantly lower fluorescence 
quantum yields in H2O, indicating that these analogs display microenvironment sensitivity. 
Furthermore, the synthesis towards a novel tricyclic adenine analog was attempted by 
extending the substrate scope of the Sonogashira cross-coupling/heteroannulation chemistry 
developed in the Hudson group
 
for cytidine analogs to adenine analogs. However, unlike the 
cytidine scaffold, the 7-deazaadenine substrate did not cyclize under the Sonogashira cross-
coupling/heteroannulation reaction conditions to give the tricyclic adenine and the straight 
cross-coupled product was obtained in moderate yield.  
 iii 
 
Lastly, an intrinsic nucleobase quencher was synthesized via the azo coupling reaction 
between 5-diazouracil and N,N-dimethylaniline. Fluorescence quenching experiments were 
performed between the nucleobase quencher and the fluorophores phenylpyrrolocytidine 
(pC), and pyrene to determine viable FRET pairs for use in molecular beacon constructs. 
Keywords 
Peptide nucleic acid, PNA, 5-aminouracil, 9-aminoacridine, acridone, fluorescence, 
environmentally sensitive fluorescence, solvatochromicity, 7-deazaadenine, Sonogashira 
cross-coupling, intrinsic nucleobase quencher, Stern-Volmer plots. 
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Chapter 1  
1 Introduction 
1.1 Nucleic Acids1 
The origins of nucleic acids research dates back to 1868 when the Swiss chemist 
Friedrich Miescher isolated a phosphorus containing substance from human puss cells 
which he called nuclein. The nuclein that Miescher isolated was actually a mixture of 
nucleic acid and protein. In 1889, Richard Altman obtained the first protein-free material 
which he called nucleic acid. 
In 1909, Phoebus Levene began some early structural studies on nucleic acids at the 
Rockefeller Institute of Medical Research. He discovered that thymus nucleic acid, which 
was readily available from calf tissue, was resistant to basic hydrolysis but hydrolyzed by 
acid. He also found that nucleic acids from plants and yeast were hydrolyzed readily by 
base. In 1911, Levene and coworkers crystallized D-ribose from plant nucleic acid and 
also went on to isolate 2-deoxy-D-ribose from animal nucleic acid (Figure 1). 
 
Figure 1: D-ribose and 2-deoxy-D-ribose. 
In 1879, Albrecht Kossel isolated and described the heterocyclic components that are 
present in nucleic acid. These include the purines, adenine and guanine, and the 
pyrimidines, cytosine and thymine (Figure 2). 
 
2 
 
 
Figure 2: The DNA nucleobases: adenine, guanine, cytosine and thymine. 
Up until the 1940s, it was believed that hydrolysis of nucleic acids gave the appropriate 
bases in equal relative proportions. This misconception led to the general acceptance of a 
tetranucleotide hypothesis for the structure of both animal and plant nucleic acids. While 
the tetranucleotide hypothesis was generally accepted among the scientific community it 
imposed invariance on the structure of nucleic acids which denied them any role in 
biological diversity. However, in 1944, Oswald Theodore Avery published his ground 
breaking work on the transforming activity of bacterial DNA, which showed that DNA 
was responsible for completely transforming the behaviour of bacteria.
2
 This contrasted 
the tetranucleotide hypothesis and demanded a reinvestigation of nucleic acid structure. 
In 1952, Erwin Chargaff studied the base composition of DNA from a variety of sources 
and showed that the composition of the bases, A, G, T and C varies from one species to 
another.
3
 He also found that the number of adenine units equals the number of thymine 
units and the number of guanine units equals the number of cytosine units.
3
 This 
disproved Levene’s widely accepted tetranucleotide hypothesis, which called for equal 
proportions of all four bases in DNA. Although Chargaff did not make the connection 
himself, his research hinted towards the base pair makeup of DNA. Chargaff’s work 
would later help James Watson and Francis Crick deduce the double helical structure of 
DNA. 
A major piece of the puzzle in determining the structure of DNA came in 1953 from 
King’s College in London England. There, Maurice Wilkins observed the importance of 
keeping the DNA fibers in a moist state and an X-ray crystallographer named Rosalind 
Franklin found that the X-ray diffraction pattern obtained from these fibers showed the 
existence of an A-form of DNA at low humidity and a B-form of DNA at high humidity. 
Both the A and B-forms of DNA were highly crystalline and helical in structure. This led 
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Franklin to hypothesize that the phosphate groups were exposed to water on the outside 
of the helix, while the bases were on the inside of the helix.  
Also in 1953, James Watson deduced that the number of nucleotides in the unit 
crystallographic cell favoured a double stranded helix. Francis Crick recognized the 
symmetry implications of the monoclinic C
2
 space group of the A-form diffraction 
pattern. He concluded that there had to be local twofold symmetry axes normal to the 
helix, this called for a double stranded helix whose two chains run in opposite directions.  
The last piece of the problem was to figure out how the bases were connected to each 
other. Some years earlier, Gulland concluded that the DNA bases were joined together by 
hydrogen bonds. Thus, Watson began to experiment with models using the enol 
tautomers of the bases and paired like with like. However this structure was rejected 
because it had the wrong symmetry for B-DNA. Self-pairing was also rejected because it 
was not in accordance with Chargaff’s 1:1 base ratios. Finally Watson experimented with 
models using the keto tautomers of the bases and paired adenine with thymine and 
guanine with cytosine. At last he found a simple relation involving two hydrogen bonds 
for an A-T pair and three hydrogen bonds for a G-C pair (Figure 3). Thus in 1953 the 
structure of DNA had been solved.
4
 As a result, the Nobel prize for chemistry in 1962 
was awarded to Watson, Crick and Wilkins. 
 
Figure 3: Watson/Crick base pairing for G-C and A-T. 
The elucidation of the structure of DNA marked the end of the classical period in the 
study of nucleic acids and the beginning of molecular biology. It soon became evident 
that locked into the sequence of nucleotide bases in the DNA of a cell was all the 
information required to specify the variety of biological molecules needed to carry out 
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the functions of that cell. For example, from the DNA duplex structure, genetic 
information is stored, accessed and replicated as a linear nucleotide code. In conjunction 
with DNA, RNA is the biopolymer which is responsible for the transportation of genetic 
information from DNA to the ribosome, the site of protein manufacturing. This flow of 
genetic information, DNA transcribed into RNA which is ultimately translated into 
protein, constitutes the central dogma of molecular biology set forth by Francis Crick in 
1970.
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During this period, scientists have devoted much time and effort toward exploring nucleic 
acid structure and function. Fluorescence spectroscopy is a very attractive technique for 
studying nucleic acids, as it is easily accessible, versatile and provides real time 
information with excellent sensitivity.
6
 Covalent attachment of traditional fluorophores 
such as fluorescein or rhodamine to the phosphate backbone, sugar or nucleobase is the 
most common method to fluorescently label nucleic acids.
7
 However, a major drawback 
of this method is that these molecules perturb the native structure of nucleic acids.
6
 As a 
result, traditional fluorophores are often covalently attached to nucleic acids via long 
linkers in order to minimize structural perturbations.
6
 Since the fluorescent reports are 
located far away from the site of interest, covalent modification of nucleic acids with 
traditional fluorophores via long linkers does not paint a clear picture of what is 
happening at or near the region of interest. To that end, fluorescent nucleosides and 
analogs have long interested chemists and biochemists involved in the study of nucleic 
acids.
8,9 
Ideally these analogs are structurally small such that they do not perturb the 
native structure of nucleic acids.
8,9
 Moreover, they possess ideal photophysical properties 
for studying nucleic acids such as red-shifted absorption and emission maxima compared 
to the natural nucleobases and high fluorescence quantum yields and fluorescence 
lifetimes.
8,9
 Due to the relative scarcity of naturally occurring fluorescent nucleosides, 
there has been increasing focus on the synthesis of analogs. Before looking at some 
examples of fluorescent nucleoside analogs in the literature, a brief introduction of 
fluorescence spectroscopy is warranted. 
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1.2 Fluorescence Spectroscopy 
Fluorescence is a photophysical process that involves emission of a photon from a singlet 
excited state to the ground state subsequent to absorption of a photon by a 
chromophore.
10
 This process is illustrated in the Jablonski diagram (Figure 1).
10
 In the 
simplified Jablonski diagram below, So represents the ground electronic singlet state of a 
molecule where as S1 and T1 represent the first excited electronic singlet state and the first 
excited electronic triplet state. Upon absorption of light by a molecule, a number of 
pathways are possible for transitions back to the ground electronic singlet state. From the 
lowest vibrational energy level of S1 the molecule can undergo internal conversion (IC) 
to the various vibrational energy levels of So followed by vibrational relaxation (VR).
11
 
Fluorescence is also possible resulting in radiative decay from the lowest vibrational 
energy level of S1 to the various vibrational energy levels of So. Intersystem crossing 
(ISC) from S1 to T1 is also possible and from the lowest vibrational energy level of T1 the 
molecule can undergo internal conversion and vibrational relaxation back to So. The 
molecule can also undergo phosphorescence as a result of radiative decay from T1 to So.  
 
Figure 4: Jablonski diagram illustrating fundamental photophysical processes.  
The fluorescence properties of a system are governed by the excitation and emission 
wavelengths, the fluorescence quantum yield, and lifetime of the excited state. 
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Fluorescence quantum yield is defined as the ratio of the number of molecules that 
fluoresce to the total number of excited molecules, or the ratio of photons emitted to 
photons absorbed (see equation 1 below).
10
 
∅𝑓 =  
𝑘𝑓
𝑘𝑓+𝑘𝑛𝑟
    (eq. 1) 
In equation 1, kf represents the first order rate constant for fluorescence relaxation and knr 
represents the rate constant for radiationless relaxation.  
 The excited state lifetime, τo, represents the sum of radiative and radiationless 
processes that the excited fluorophore undergoes upon decaying back to the ground state. 
The fluorescence lifetime, τ, is the portion responsible for emitting a photon and is 
related to the quantum yield of the fluorophore (see equation 2).
10
 
∅𝑓 =  
𝜏
𝜏𝑜
       (eq. 2) 
For many fluorophores the measurable parameters of fluorescence, i.e. emission 
maximum, quantum yield and fluorescence lifetime are sensitive to the local environment 
of the fluorophore. Researchers have exploited the sensitivity of fluorophores to various 
environmental parameters such as pH, polarity, viscosity, presence of quenchers, and so 
on. In turn they have also designed fluorescent probes with the appropriate excitation and 
emission wavelengths that minimize interference by other emissive species. Thus it is this 
selective excitation as well as the sensitivity of fluorophores to various environmental 
parameters that makes fluorescence such an effective technique for studying nucleic 
acids. 
 Fluorescence Quenching and Resonance Energy Transfer 1.2.1
Two common processes that cause loss of fluorescence intensity are static and dynamic 
quenching. Static quenching occurs when a non-fluorescent ground state complex is 
formed.
10
 Dynamic quenching is described by the Stern-Volmer equation (see equation 3) 
and is characterized by a linear relationship between the quenching effect and the 
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quencher concentration.
10
 Deviation from linearity often infers the involvement of static 
quenching. 
                  
𝐼𝑜
𝐼
= 1 + 𝐾𝑠𝑣[𝑄] = 1 + 𝑘𝑞𝜏𝑜[𝑄]       (eq. 3) 
In equation 3, Ksv is the Stern-Volmer quenching constant, kq is the bimolecular 
quenching constant, τo is the unquenched lifetime and [Q] is the quencher concentration. 
A related phenomenon involves resonance energy transfer, a nonradiative transfer of 
excitation energy between two chromophores, often referred to as donors and acceptors.
10
 
Different mechanisms can facilitate energy transfer. The Dexter mechanism operates over 
short distances and requires intermolecular orbital overlap.
11
 The Förster mechanism 
(FRET) operates over larger distances (30 – 60 Å) and occurs when the excited state 
dipole moment of a donor induces electron excitation of an acceptor.
12
 FRET efficiency 
depends on the inverse sixth power of intermolecular separation, thus making it useful for 
studying distances similar to those of biological macromolecules such as nucleic acids. 
1.3 Fluorescent Nucleobase Analogs 
The literature shows us that uridine/deoxyuridine and uracil nucleobase analogs are the 
most abundant due to it offering the simplest chemistry relative to the other 
nucleobases.
8,9
 However, over the past decade, great strides have been made in the 
variety of fluorescent cytidines, adenosines and guanosines prepared.
8,9
 Based on their 
structural features, these fluorescent nucleobase analogs can be divided into four main 
categories, naturally occurring fluorescent nucleobase analogs, expanded nucleobases, 
extended nucleobases and isomorphic nucleobases.
8,9
 The purpose of the following 
sections is not to provide a comprehensive review of fluorescent nucleobase analogs, but 
to highlight the structural characteristics that improve the photophysical properties 
compared to the native nucleobases. 
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 Naturally Occurring Fluorescent Nucleobases 1.3.1
Some examples of naturally occurring fluorescent nucleobase analogs include 2-
aminopurine (2-AP)
13
 and the pteridine analogs studied by Hawkins and co-workers
14-18
 
(Figure 5, Table 1). Although these compounds exhibit desirable photophysical properties 
for studying nucleic acids, i.e. red-shifted absorption and emission maxima compared to 
the canonical nucleosides, high fluorescence quantum yields and fluorescence lifetimes, 
due to the relative scarcity of naturally occurring fluorescent nucleosides, researchers 
have focused on the synthesis of analogs. 
 
Figure 5: Selected examples of naturally occurring fluorescent nucleosides (dr = 2’-
deoxyribose) 
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Structure (dr = 2’-
deoxyribose) 
λabsorbance 
(nm) 
λemission 
(nm) 
ΦF 
(solvent) 
τ (ns) 
(solvent) 
 
303 370 0.68 
(H2O) 
7.0 
(H2O) 
 
310 430 0.48 
(10 mM Tris 
buffer, pH 7.5) 
4.8 
(10 mM Tris 
buffer, pH 7.5) 
 
320 430 0.39 
(10 mM Tris 
buffer, pH 7.5) 
3.8 
(10 mM Tris 
buffer, pH 7.5) 
 
350 430 0.88 
(10 mM Tris 
buffer, pH 7.5) 
6.5 
(10 mM Tris 
buffer, pH 7.5) 
 
340 431 0.70 
(10 mM Tris 
buffer, pH 7.5) 
6.4 
(10 mM Tris 
buffer, pH 7.5) 
Table 1: Summary of the selected naturally occurring fluorescent nucleosides 
presented and their corresponding photophysical properties. 
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 Expanded Nucleobases 1.3.2
The fusion of aromatic rings onto the purine and pyrimidine scaffold results in an 
extension of conjugation which in turn enhances the photopysical properties compared to 
the native nucleobases. Some examples of expanded nucleobase analogs include 
benzoadenosine,
19
 napthothymine,
20
 methoxybenzodeazaadenosine,
21-23
 and the 
phenoxazine nucleobase analog tC
24-26
 (Figure 6). All of these compounds exhibit red-
shifted absorption and emission maxima and moderate to high fluorescence quantum 
yields. The photophysical properties of these analogs are summarized in Table 2. 
 
Figure 6: Selected examples of expanded nucleobases (R = 2’-deoxyribose). 
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Structure (dr = 
2’-deoxyribose) 
λabsorbance 
(nm) 
λemission 
(nm) 
Φ 
(solvent) 
τ (ns) 
(solvent) 
   
340 395 0.44 
(H2O) 
3.7 
(H2O) 
 
360 434 0.82 
(aqueous 
buffer, pH 7) 
nr 
 
327 397, 427 0.118 
(50 mM 
sodium 
phosphate, 0.1 
M sodium 
chloride, pH 7) 
nr 
 
375 500 0.17 
(aqueous 
buffer, pH 7.5) 
3.7 
Table 2: Summary of the selected expanded nucleobases presented and their 
corresponding photophysical properties (nr = not reported). 
 
 Extended Nucleobases 1.3.3
Chromophores that are linked or conjugated to the natural nucleobases, via rigid or 
flexible linkers, result in extended fluorescent nucleobase analogs.
8,9
 The connection of 
known fluorophores through nonconjugating linkers results in nucleobase analogs with 
photophysical properties similar to that of the parent fluorophore.
8,9
 In contrast, 
attachment of known fluorophores via conjugated linkers usually results in a new 
chromophore with its own unique photophysical properties.
8,9
 Some examples of 
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extended nucleobase analogs include 2-ethynyl-6-cyanonaphthalene-8-aza-7-deaza-2’-
deoxyadenosine (A
CN
),
27
 2-phenylpropyl-2’-deoxyadenosine,28-29 pyU23 and 5-(1-
pyrenyl)-2’-deoxyuridine,30-31 (Figure 7). Similarly to the expanded nucleobases, these 
compounds also exhibit red-shifted absorption and emission maxima and moderate to 
high fluorescence quantum yields. The photophysical properties of these extended 
nucleobase analogs are summarized in Table 3. 
 
Figure 7: Selected examples of extended nucleobases (R = 2’-deoxyribose or ribose). 
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Structure (dr = 2’-deoxyribose r 
= ribose) 
λabsorbance 
(nm) 
λemission 
(nm) 
Φ 
(solvent) 
τ (ns) 
(solvent) 
 
 
327 
323 
327 
 
 
375 
399 
429 
 
 
0.29 (1,4-dioxane) 
0.37 (ethanol) 
0.35 (DMF) 
 
 
nr 
nr 
nr 
 
292 385 0.011 (H2O) 6.22 
(H2O) 
 
341 397 0.2  
(aqueous 
phosphate buffer, 
pH 7.0) 
nr 
 
342 474 0.027 (methanol) nr 
Table 3: Summary of the selected extended nucleobases presented and their 
corresponding photophysical properties (nr = not reported). 
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 Isomorphic Nucleobases 1.3.4
Isomorphic nucleobase analogs are structurally similar to the native nucleobases, 
however they possess enhanced photophysical properties. Some examples of isomorphic 
nucleobase analogs are 8-vinyl-6-aminopurine,
32-33
 8-(fur-2-yl)guanosine,
34
 thieno[3,4-
d]-uridine,
35
 and phenylpyrrolocytidine
36
 (Figure 8). Similarly to the expanded and 
extended nucleobases, these isomorphic nucleobase analogs also exhibit red-shifted 
absorption and emission maxima and relatively high fluorescence quantum yields. The 
photophysical properties of these compounds are summarized in Table 4. 
 
Figure 8: Selected examples of isomorphic nucleobases (R = 2’-deoxyribose or 
ribose). 
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Structure (dr = 2’-
deoxyribose, r = ribose) 
λabsorbance 
(nm) 
λemission 
(nm) 
Φ 
(solvent) 
τ (ns) 
(solvent) 
 
290 382 0.66 
(25mM 
HEPES 
buffer, pH 
7.5) 
4.7 
 
294 378 0.57 
(H2O) 
nr 
 
304 412 0.48 
(H2O) 
nr 
 
362 454 0.31 
(H2O) 
nr 
Table 4: Summary of the selected isomorphic nucleobases presented and their 
corresponding photophysical properties (nr = not reported). 
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 Applications of Fluorescent Nucleobase Analogs 1.3.5
1.3.5.1 Single Nucleotide Polymorphism (SNP) Detection 
Many diseases arise from variations within the human genome. For instance cystic 
fibrosis and sickle cell anemia are caused by base sequence changes in a single gene. The 
most common type of human genetic variation is the single nucleotide polymorphism 
(SNP).
9
 A useful technique for SNP detection relies on fluorescent nucleoside analogs.
9
 
In more detail, a fluorescent oligonucleotide complementary to the region of interest is 
hybridized to a target DNA sequence.
9
 The emissive nucleoside probe is usually placed 
across from the base of interest, resulting in either a red-shift or blue-shift in the emission 
wavelength, an increase or decrease in the fluorescence quantum yield or a change in the 
length of the excited state lifetime.
9
 
In 2003 Saito and co-workers designed methoxybenzodeazaadenosine (
MD
A) a base-
discriminating fluorescent (BDF) nucleoside which is used to detect single nucleotide 
polymorphisms (SNPs) (figure 5, table 1).
21-23
 Incorporation of 
MD
A into a single 
stranded oligodeoxynucleotide, 5’-d(CGCAATMDAATAACGC)-3’, resulted in a massive 
decrease in fluorescence intensity with a quantum yield value of 0.005.
21-23
 A similar 
result was observed for double stranded duplexes containing 
MD
A, quantum yields ranged 
from <0.0005 in the fully complementary duplex to 0.0006 when the base opposite 
MD
A 
was adenine.
21-23
 Interestingly a DNA duplex containing guanine opposite of 
MD
A 
exhibited a dramatic increase in fluorescence intensity with a quantum yield of 0.020.
21-23
 
More importantly however, a quantum yield of 0.081 was obtained for a DNA duplex 
with cytidine opposite from 
MD
A.
21-23
 Although the fluorescence of an 
MD
A containing 
duplex was significantly depressed when the flanking base pair was a G/C base pair, thus 
hampering the general utility of this method, the authors successfully demonstrated SNP 
detection of the C SNP sequence in the human breast cancer 1 gene (BRCA1) using this 
“base discriminating fluorophore” (BDF) technology.21-23  
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1.3.5.2 Nucleic Acid Structure and Function 
Nucleic acids can be found in various forms and aggregated states, which may be related 
to a specific cellular function.
8
 Incorporation of emissive nucleosides into nucleic acid 
strands can fluorometrically report hybridization, folding and conformational changes.
8
 
Moreover, fluorescent nucleoside analogs have been used to design assays that monitor 
enzymes operating on nucleic acids such as RNase H.
37
 
In 2010, Hudson and co-workers demonstrated that 6-phenylpyrrolocytosine (PhpC) 
(figure 7, table 3), serves as a cytosine mimic in terms of its recognition by enzymes.
37
 
To that end, a DNA – RNA heteroduplex containing a single PhpC insert was used to 
develop an RNase H assay that fluorometrically reports on the cleavage of the enzyme 
substrate.
37
 In more detail, PhpC was incorporated into the RNA single strand PhPC-1 
(5’-GAUCUGAGCCUGGGAGPhpCU-3’), and hybridized with its complementary 
DNA target. In the DNA – RNA heteroduplex, PhpC exhibited low fluorescence. 
However, treatment with HIV-1 RT RNase H generated an RNA tetranucleotide bearing 
PhpC, and rapidly dissociated from its DNA complement resulting in a concomitant 
drastic increase in fluorescence intensity.
37
     
1.3.5.3 Nucleic Acid Microenvironment 
Nucleic acids suffer different types of perturbations such as nucleobase damage, 
depurination/depyrimidation and base flipping.
8
 Fluorescent nucleoside analogs that are 
sensitive to their local microenvironment are useful tools for studying these 
perturbations.
8
 Furthermore, fluorescent nucleosides have been used to assess the polarity 
of nucleic acid grooves.
27 
In 2014, Saito and co-workers designed an environmentally sensitive fluorescent 8-aza-7-
deaza-2’-deoxyadenosine derivative (ACN), with dual fluorescence for the specific 
detection of thymine (figure 6, table 2).
27
 The authors report that the emission of this 
fluorescent adenosine analog is shifted to longer wavelengths in highly polar solvents and 
thus exhibits typical solvatofluorochromicity, which can be attributed to intramolecular 
charge transfer (ICT) fluorescence.
27
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Measurement of the fluorescence spectra of DNA1 (5’-d(CGCAATACNTAACGC)-3’), in 
the absence or presence of complementary strands showed that the fluorescence emission 
of the single strand was relatively weak.
27
 However when complementary DNA strands 
were added the fluorescence intensity of the duplexes was significantly enhanced.
27
 In 
more detail, when DNA1 was hybridized with a complementary sequence containing an 
abasic site across from the fluorescent adenosine analog, a strong broad fluorescence 
emission band was observed at 417 nm.
27
 Furthermore when DNA1 was hybridized with 
complementary sequences containing A or C across form the fluorescent adenosine 
analog, strong broad emission bands were observed at 409 and 405 nm respectively.
27
 In 
contrast, when DNA1 was hybridized with a complementary sequence containing G 
across form the fluorescent adenosine analog, the fluorescence emission considerably 
decreased due to quenching by G.
27
 Interestingly, in the perfectly matched DNA duplex 
the fluorescence maximum was largely blue shifted at 362 and 381 nm and an enhanced 
dual fluorescence emission with vibronic structures was observed.
27
 Thus changing the 
base across from the surrogate fluorescent adenine caused a change in the fluorescence 
intensity and emission wavelength of the ODN probe. 
1.4 Peptide Nucleic Acid (PNA) 
Peptide nucleic acid (PNA) was first reported in 1991 by Nielsen et al.
38
 and is a DNA 
mimic comprised of a polyamide backbone (Figure 9).
38-39
 Over the years, PNA has been 
exploited by researchers due to its ability to form stable base pairs with complementary 
DNA or complementary RNA sequences with high stability and fidelity.
38-39
 In contrast 
to DNA and RNA, PNA is more suitable for in vivo applications since the nonstandard 
backbone is not recognized by nucleases, resulting in increased stability of PNA in living 
cells.
39
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Figure 9: Comparison of the structures of DNA and PNA 
1.5 Rationale 
The focus of this thesis is on nucleobase modified PNA and DNA to expand the 
repertoire of available nucleobase analogs used in the study of nucleic acids. Although 
there exists a wide variety of fluorescent nucleobase analogs, the search for an ideal 
analog with optimal properties, i.e., high fluorescence quantum yield, red-shifted 
absorption maxima, not destabilizing to hybridization, ability to provide nucleobase 
discrimination, and the ability to report differences in the local environment through a 
change in fluorescence intensity or emission wavelength is very much still a challenge. 
The literature also shows us that certain fluorescent nucleobase analogs are 
underrepresented, especially analogs of adenine and guanine.
8,9
 To that end, this thesis 
focused on the synthesis of novel fluorescent 7-deazaadenosine analogs and chemistry 
toward a novel tryciclic 7-deazaadenine analog. 
Lastly, the synthesis of an intrinsic nucleobase quencher was also undertaken to 
overcome some of the limitations associated with traditional FRET based molecular 
beacons which will be further discussed in chapter 5. 
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1.6 Outline of Thesis 
The focus of this thesis is on nucleobase modified peptide nucleic acid (PNA) and DNA. 
Chapter 2 describes the synthesis of an acridine-labelled 5-aminouracil PNA monomer, 
for the purpose of investigating its potential as a base-discriminating fluorophore.  
Chapter 3 describes the synthesis and photophysical characterization of novel fluorescent 
7-deazaadenosine analogs. The photophysical properties of these 7-deazaadenosine 
analogs were studied in solvents of different polarity to evaluate their potential for use as 
environmentally sensitive fluorescent probes in DNA.  
Chapter 4 describes efforts toward the synthesis of a novel tricyclic 7-deazaadenine 
analog. The goal of this research project was to synthesize a novel tricyclic adenine 
analog by extending the substrate scope of the Sonogashira cross-
coupling/heteroannulation chemistry developed in the Hudson group for cytidine analogs 
to adenine analogs.  
Lastly, chapter 5 focuses on the synthesis, fluorescence quenching studies and efforts 
toward the oligomerization of a novel intrinsic fluorescence quencher, 5-(4-
dimethylaminophenyl)azouridine, which incorporates the key structural feature of the 
universal quencher DABCYL. The goal of this work was to synthesize a base pairing 
competent quencher for use in novel stemless molecular beacon constructs. 
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Chapter 2  
2 5-(Acridin-9-ylamino)uracil a hydrolytically labile 
nucleobase modification in peptide nucleic acid (PNA) 
2.1 Introduction 
Natural nucleic acids are not appreciably fluorescent,
1
 thus engendering them with 
fluorescence dramatically expands their range of applications.
2
 Nucleobases that are also 
luminophores may exhibit fluorescence that is dependent on their chemical environment, 
thus being able to report the difference between the single-stranded state and duplex as 
well as the difference between a complementary base and a mismatch. Nucleobases that 
possess this ability have been termed “base-discriminating fluorophores” (BDFs).3 BDFs 
have uses in fluorimetric sequence detection, the detection of single nucleotide 
polymorphorisms, reporting enzymatic processing of nucleic acids, and the ability to 
visualize their trafficking within biological systems.
2,4
  
Our approach to modification of the nucleobase is such that it retains Watson–Crick base-
pairing yet possesses fluorescent properties. Acridine and 9-aminoacridine are well-
known fluorophores,
5
 thus we set out to synthesize the chromophore-labelled nucleobase 
5-(acridin-9-ylamino)uracil, U
A
, derived from 5-aminouracil, which will be described 
(Figure 10).
6
 Although the development of fluorescent uridine analogues has been 
extensively investigated,
2,7
 the derivatization of 5-aminouracil with chromophoric 
molecules remains relatively unexplored.
8
 The spectroscopic and biophysical properties 
of this compound will also be described. 
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Figure 10: Acridine-labelled 5-aminouracil PNA monomer U
A
. 
2.2 Results and Discussion  
For some time, we have pursued a minimalist approach to the transformation of 
essentially nonfluorescent natural nucleobases into base-pairing competent intrinsic 
fluorophores. Approaches for the transformation of uracil to a luminophore have focused 
predominantly on derivatization at C5.
7
 In this vein, 5-aminouracil represents a 
convenient starting material for derivatization with small, amine-reactive fluorophores. 
For example, the acridine-labelled base can be accessed via reaction with 9-
chloroacridine. Further standard transformations yield a monomer suitable for peptide 
nucleic acid oligomer synthesis (Scheme 1). The low yield of compound II-2 is due to 
formation of the undesired dialkylated product; however, the mono- and di-alkylated 
products are easily separated by column chromatography. 
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Scheme 1: Synthesis of the acridine-labelled 5-aminouracil PNA monomer. 
 Spectroscopic properties of acridine-labelled nucleobase 2.2.1
Compound II-2 exhibits strong absorption peaks at 260 and 411 nm in the UV-vis 
spectrum, which is more similar to 9-aminoacridine than acridine.
5
 The longer 
wavelength absorption is well separated from the absorption of native nucleic acids and 
possesses high molar absorptivity (ε = 11200/(mol/L) cm, at λ = 411 nm, in EtOH), 
possibly providing a good route to selective excitation of the modified base. This 
compound, and its congeners, were also visibly fluorescent under illumination by a 
handheld UV lamp (λ = 360 nm) while in solution or as a solid adsorbed on to a TLC 
plate. However, when the fluorescence emission intensity was quantitated, it was found 
to be rather weak. The relative quantum yield in EtOH was determined to be 0.093% 
measured against 9,10-diphenylanthracene, whereas the fluorescence quantum yield of 9-
aminoacridine in EtOH is 0.61.
9
 It has been argued that 9-aminoacridine possesses a 
planar conformation with respect to the exocyclic nitrogen, but non-hydrogen 
substituents on the 9-amino group cause a conformational change preventing effective 
conjugation of this group to the acridine moiety.
9
 Despite the loss in fluorescence 
26 
 
emission intensity, 9-N-substituted aminoacridines have been shown to be responsive to 
changes in solvent polarity.
9
 
 PNA Oligomerization 2.2.2
PNA synthesis was accomplished with the assistance of an automated synthesizer on the 
5 μmol scale using manufacturer supplied cycles for fluorenylmethyloxycarbonyl 
(Fmoc)-based oligomerization with tert-butyloxycarbonyl (Boc)-nucleobase protection.
10
 
The custom monomer, U
A
, was successfully incorporated into adjacent central positions 
in a 14-mer PNA oligomer, N-terminus-Lys-C-T-T-T-C-C-U
A
-U
A
-C-A-C-T-G-T-Lys-C-
terminus. The peptide was cleaved from the resin, and isolated and purified according to 
previously reported procedures.
11
 The reason for incorporation of two contiguous uracil 
analogues was to investigate the possibility of inducing excimer formation to visualize a 
fluorescence change upon hybridization to somewhat compensate for the low 
fluorescence quantum yield of U
A
. 
 Hybridization studies 2.2.3
The stability of complexes formed with cDNA or with sequences possessing a central 
mismatch was evaluated by temperature dependent UV-vis spectroscopy (Table 5). The 
fully complementary PNA–DNA duplex has a thermal denaturation transition 
temperature (Tm) value of 59 °C, which is approximately 15 °C higher than the fully 
cDNA–DNA duplex reported by Gambari and co-workers12 in 2001. Single mismatch 
discrimination across from U
A
 was also determined and corresponded to the base pairs 
U
A
-G, U
A
-C, and U
A
-T (Table 5). The Tm values reported in Table 5 suggest that the 14-
mer PNA oligomer can effectively discriminate between the fully complementary PNA–
DNA duplex and the PNA–DNA duplexes containing a single base pair mismatch. In 
each case, the Tm values of the mismatched duplexes are all lower than the Tm value of 
the fully complementary duplex. The duplex containing a U
A
-T mismatch is significantly 
stabilized compared to the C and G mismatched duplexes. It is possible that greater 
stability is due to a two H-bond pair formed by shearing of the thymine and U
A
 relative to 
the helical axis (Figure 11).
13
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PNA-DNA duplex Tm (
o
C; +/- 1 
o
C) 
N-term-Lys-C-T-T-T-C-C-U
A
-U
A
-C-A-C-T-G-T-Lys-C-term 
5’-G-A-A-A-G-G-A-A-G-T-G-A-C-A-3’ 
59.0 
N-term-Lys-C-T-T-T-C-C-U
A
-U
A
-C-A-C-T-G-T-Lys-C-term 
5’-G-A-A-A-G-G-A-C-G-T-G-A-C-A-3’ 
40.5
a
 
N-term-Lys-C-T-T-T-C-C-U
A
-U
A
-C-A-C-T-G-T-Lys-C-term 
5’-G-A-A-A-G-G-A-G-G-T-G-A-C-A-3’ 
46.5 
N-term-Lys-C-T-T-T-C-C-U
A
-U
A
-C-A-C-T-G-T-Lys-C-term 
5’-G-A-A-A-G-G-A-T-G-T-G-A-C-A-3’ 
52.5 
Table 5: Thermal denaturation transition temperatures (Tm) for PNA−DNA 
duplexes: Oligonucleotide complexes were 2 μmol/L in a buffer containing 100 mmol/L 
NaCl, 10 mmol/L Na2HPO4, and 0.1 mmol/L EDTA at pH 7. 
a
The renaturation data was 
used to extract the Tm value instead of the melt data, which exhibited a larger error (43 ± 
2 °C). 
 
                 
Figure 11: Proposed base pair between U
A
 and T 
 
 Chemical behaviour of UA 2.2.4
During the temperature cycling in aqueous buffer for evaluation of the hybridization 
properties of the PNA, it was noted that the initially pale yellow solutions developed 
visible blue fluorescence. After a nontrivial amount of investigation, we determined that 
the fluorescence was due to the presence of acridone. Acridone is highly fluorescent, 
exhibiting quantum yield values near unity in water and alcoholic solvents,
14
 and displays 
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easily visually observed blue fluorescence emission at low concentrations. Analysis of 
the PNA oligomer by mass spectrometry after heat cycling showed that the oligomer was 
still intact; HR-MS (ESI) m/z: calcd. for C185H228N76O50: 4314.7713; found: 4314.7284 
[M + H]
+
. 
The oligomer was also analyzed using polyacrylamide gel electrophoresis (PAGE) 
according to a literature procedure.
15
 Figure 12 clearly shows two bands for the heat 
treated oligomer, a slower moving nonfluorescent band possessing a mobility similar to 
the untreated oligomer and a faster moving (smaller) fluorescent material, while only a 
single band for the oligomer without heat treatment is observed. The fluorescent band has 
been identified as acridone, whereas the other band is attributed to the fully intact 
oligomer. It was not possible to isolate the putative 5-aminouracil containing PNA, nor 
find evidence for its formation by mass spectrometry studies on the oligomer. 
The intended use of the oligomer bearing the modified bases, to potentially 
fluorimetrically report hybridization and discrimination of perfectly matched sequences 
to mismatch sequences, is not possible. The intensely fluorescent acridone (Φ = 0.83 in 
EtOH)
16
 produced during the annealing of strands effectively masks any signal from the 
modified oligomer. 
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Figure 12: PAGE analysis of unprocessed PNA oligomer (lane 1) and extensively 
heat-cycled PNA oligomer (lane 2) visualized by UV shadowing over a fluorescent 
TLC plate illuminated at 260 nm. The arrowhead indicates the presence of acridone 
displaying its typical blue fluorescence. PAGE conditions: 26% acrylamide, 1.6% 
bisacrylamide, and 8.2 mol/L urea. 
 
Due to difficulty in analyzing the oligomer and low abundance hydrolysis products, we 
turned to a model reaction to understand the chemistry (Scheme 2). When compound II-1 
was heated in water at 90 °C for 4 h the appearance of acridone was observed by thin 
layer chromatography (TLC) (Rf = 0.5, EtOAc–hexanes 1:1). The presence of acridone 
was also confirmed by low resolution mass spectrometry (calcd. for C13H9NO [M]+: 
195.1; found: 195.1) and fluorescence spectroscopy (Figure 13). 5-Aminouracil proved to 
be more difficult to identify by any of the above techniques; however, the presence of 5-
aminouracil was confirmed by HPLC (Figure 14). Upon extended heating, >24 h, 
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complete hydrolysis could be achieved and the reaction products were characterized by 
HPLC analysis (Figure 15). 
 
Scheme 2: Observed hydrolysis of compound II-1 under neutral conditions and 
plausible mechanism for the formation of the observed products. 
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Figure 13: Excitation emission spectrum of acridone in EtOH. 
 
 
 
Figure 14: HPLC analysis of 5-aminouracil (top) and co-injection of 5-aminouracil 
and the hydrolyzed mixture (bottom). Note: Chromatograms were extracted at λ = 
252 nm.  
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Figure 15: HPLC analysis of compound 1 (top), and the hydrolyzed mixture after 
heating at 90 
oC for 24 hours (bottom). Note: Chromatograms were extracted at λ = 
252 nm. 
It has been reported that bulky substituents on the 9-amino group prevents coplanarity of 
the nitrogen with the acridine nucleus, thus resulting in a decrease in the chemical 
stability of aminoacridines.
17
 For example, in the series 9-aminoacridine, 9-
methylaminoacridine, and 9-dimethylaminoacridine, there is a general decline in stability 
toward alkaline hydrolysis.
17,18
 A similar trend is observed with neutral and acid 
hydrolysis whereby 9-aminoacridine is more stable than 9-N-dialkylaminoacridines.
19
 
We have noted that the thermal lability of the 5-(acridin-9-ylamino)uracil moiety is 
affected by N1-substitution. For example, complete hydrolysis of II-1 was achieved by 
heating in water at 90 °C for over 24 h, while similar treatment of II-5 led to much less 
conversion (<10% by NMR analysis, data not shown). Likewise, our studies indicate that 
heating of the PNA oligomer containing the modified base under the conditions used to 
measure the Tm leads to a relatively small amount of conversion, which is estimated to be 
less than 10% based on the amount of acridone released and our inability to detect the 5-
aminouracil containing PNA by HPLC–MS or PAGE analysis. Separate experiments 
incubating the oligomer for 4 h at 90 °C and analysis of the amount of released acridone 
versus intact oligomer shows about 15% conversion. Thus, the Tm values reported are 
valid for the 5-(acridin-9-ylamino)uracil modified PNA. The slow release of acridone 
from the oligomer argues against its long term storage. As well, the acridinyl moiety 
would not be a useful thermally labile protecting group as a route to 5-aminouracil 
modified PNA because of the slow rate of release. 
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2.3 Conclusions 
The optimized synthesis of a weakly fluorescent nucleobase derived from 5-aminouracil 
was developed. The modified monomer was incorporated into a PNA oligomer. Thermal 
denaturation studies of DNA complexes with this oligomer illustrated its ability to 
discriminate between a fully matched complementary strand and the corresponding U-G, 
U-C, and U-T mismatched strands. The fluorescence of the PNA oligomer could not be 
used to study hybridization because the 5-(acridin-9-ylamino)uracil modification was 
thermally labile in aqueous solution and liberated the highly fluorescent acridone moiety 
obscuring the signal from the PNA. Despite not being an effective BDF, the ease at 
which the modification was introduced indicates the potential of this chemical route for 
the introduction of chemically modified nucleobases into PNA. 
2.4 Future Work 
For some time now, we have been interested in the synthesis and photophysical 
properties of other structurally small, environmentally responsive fluorophores derived 
from 5-aminouracil. For instance, treatment of 5-aminouracil with the amine reactive 
fluorophore NBD chloride should produce a novel nucleobase analog with interesting 
fluorescent properties (Scheme 3). Moreover, further standard transformations would 
yield a monomer suitable for incorporation into a PNA oligomer. The photophysical 
properties of the novel PNA oligomer can then be evaluated for use as a potential 
fluorescent probe to study nucleic acids. 
 
Scheme 3: Proposed synthesis of a 5-aminouracil PNA monomer derivatized with 
the amine reactive fluorophore NBD chloride. 
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2.5 Experimental 
5-(Acridin-9-ylamino)pyrimidine-2,4(1H,3H)-dione (II-1): 
                                                   
                                                      
A mixture of 9-chloroacridine (2.15 g, 10.1 mmol) and phenol (11.41 g, 121.2 mmol) was 
heated to 80 
o
C. Once the phenol had melted, 5-aminouracil (1.22 g, 9.60 mmol) was 
added to the stirred solution at 80 
o
C and the reaction was further heated to 120 
o
C. The 
reaction was stirred at 120 
o
C for 2 h under an atmosphere of nitrogen. The reaction 
mixture was then cooled to room temperature and treated with 200 mL of 1M NH4OH to 
precipitate an orange/brown solid. The crude product was collected by vacuum filtration, 
triturated in boiling EtOH for 2 h and collected by vacuum filtration again to afford 
compound II-1 in 71 % yield. 
1
H-NMR (DMSO-d6, 400 MHz): δ 11.09 (s, 1H) 10.92 (s, 
1H), 10.60 (s, 1H), 8.45-7.75 (m, 2H), 7.70-6.80 (m, 7H). 
13
C-NMR (DMSO-d6, 400 
MHz): δ 159.5, 154.6, 150.5, 140.2, 131.3, 127.0, 126.5, 125.0, 120.5, 117.5. HRMS 
(EI): calcd. For C17H12N4O2 [M]
+
 304.0960, found 304.0959. 
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Ethyl-2-(5-(acridin-9-ylamino)-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)acetate (II-
2): 
                                                     
Compound II-1 (2.00 g, 6.58 mmol) and anhydrous K2CO3 (2.73 g, 19.7 mmol) were 
dissolved in dry DMF (32.1 mL) and cooled to –10 oC in an ice-salt bath. 
Ethylbromoacetate (0.80 mL, 7.24 mmol) was then added dropwise to the reaction 
mixture at – 10 oC. The reaction was left stirring overnight under an atmosphere of 
nitrogen, with a gradual increase in temperature due to the melting of the ice-salt bath, 
and monitored by TLC for completion, approximately 48 h. The solvent was removed 
under reduced pressure and the crude product was dissolved in dichloromethane (200 
mL) and washed with saturated NaHCO3 (2 x 100 mL), water (2 x 100 mL) and brine (2 
x 100 mL). The organic phase was collected and dried over anhydrous sodium sulfate, 
filtered and concentrated under reduced pressure. The crude product was purified via 
FCC eluting with dichloromethane:hexanes 20:80 to dichloromethane:acetone 50:50, to 
afford compound II-2 in 40 % yield. 
1
H-NMR (DMSO-d6, 400 MHz): δ 11.45 (s, 1H), 
11.00 (s, 1H), 8.35-7.90 (m, 2H), 7.60-6.80 (m, 7H), 4.54 (s, 2H), 4.18 (q, J = 7.0 Hz, 
2H), 1.23 (t, J = 7.0 Hz, 3H). 
13
C-NMR (DMSO-d6, 400 MHz): δ 168.6, 159.1, 155.3, 
150.2, 140.0, 131.7, 129.4, 127.7, 126.5, 120.6, 117.3, 61.4, 48.8, 14.2. HRMS (EI): 
calcd. For C21H18N4O4 [M]
+
 390.1328, found 390.1337. 
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2-(5-(acridin-9-ylamino)-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)aceticacid (II-3): 
                                                     
Compound II-2 (0.20 g, 0.51 mmol) was dissolved in 14.4 mL of THF and kept in an ice 
bath for 15 minutes followed by the slow drop wise addition of NaOH (2.9 mL, 2.5 M). 
The reaction mixture was removed from the ice bath and stirred at room temperature until 
TLC indicated complete consumption of the starting material, approximately 2 hours. A 
yellow solid had precipitated from the reaction mixture and the remaining liquid was 
slowly decanted. To the yellow solid was added 40 mL of 1 M HCl. The product was 
filtered and dried under vacuum to afford compound II-3 in 90 % yield which was used 
without further purification. 
1
H-NMR (DMSO-d6, 600 MHz): δ 13.38 (bs, 1H), 11.93 (s, 
1H), 10.99 (bs, 1H), 8.70-7.45 (m, 9H), 4.61 (s, 2H). 
13
C-NMR (DMSO-d6, 400 MHz): δ 
169.3, 159.7, 155.9, 150.1, 142.6, 139.5, 135.3, 124.9, 124.2, 119.0, 114.9, 113.7, 49.3. 
HRMS (EI): calcd. For C19H14N4O4 [M]
+
 362.1015, found 362.1003. 
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tert-butyl-2-(N-(2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)ethyl)-2-(5-(acridin-
9-ylamino)-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)acetamido)acetate (II-4): 
                                                    
Compound II-3 (0.15 g, 0.41 mmol) was dissolved in 10.3 mL of anhydrous DMF and 
cooled to 0 
o
C followed by the addition of a solution of N-[2-(Fmoc)aminoethyl]glycine-
t-butyl ester (0.15 g, 0.39 mmol) in DMF (0.065 M), Hunig’s base (0.6 mL, 3.4 mmol), 
HOBt (53 mg, 0.39 mmol) and HBTU (0.15 g, 0.39 mmol). The reaction was warmed to 
room temperature and left stirring for 24 h under an atmosphere of nitrogen. The reaction 
mixture was diluted with 60 mL of EtOAc and washed with 1 M NaHSO4 (2 x 30 mL), 
water (2 x 30 mL) and brine (2 x 30 mL). The organic layer was collected, dried over 
sodium sulfate, filtered and concentrated under reduced pressure. The crude product was 
purified via FCC eluting with dichloromethane:methanol 100:0 – 90:10 to afford 
compound II-4 in 65 % yield. Compound II-4 exists in solution as a pair of slowly 
exchanging rotamers; signals attributed to major (ma.) and minor (min.) rotamers are 
designated. 
1
H-NMR (DMSO-d6, 400 MHz): δ 11.85 (s, 1H), 8.55 (s, 2H), 8.10-7.15 (m, 
18H), 4.88 (s, ma., 1.05H), 4.67 (s, min., 0.66H), 4.32 (s, min., 0.66H), 4.02 (s, ma., 1.15 
H), 4.39-4.11 (m, 3H), 3.45 (m, 2H), 3.28 (m, 2H), 3.14 (m, 1H), 1.48 (s, min., 3H), 1.41 
(s, ma. 6H). 
13
C-NMR (DMSO-d6, 400 MHz): δ 168.4, 168.0, 167.5, 167.1, 159.6, 156.4, 
156.1, 150.1, 143.8, 142.8, 140.7, 139.5, 135.2, 127.8, 127.6, 127.3, 127.0, 125.1, 124.5, 
124.0, 120.1, 119.1, 118.9, 114.2, 109.6, 82.1, 81.0, 65.5, 46.7, 27.7. HRMS (EI): calcd. 
For C42H41N6O7 [M + H]
+
 741.3037, found 741.3038. 
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2-(N-(2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)ethyl)-2-(5-(acridin-9-
ylamino)-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)acetamido)acetic acid (II-5): 
                                                                                                              
Compound II-4 (99 mg, 0.13 mmol) was dissolved in 3 mL of anhydrous CH2Cl2 and 
cooled to 0 
o
C followed by the slow dropwise addition of TFA (2 mL). The reaction was 
stirred for 30 minutes at 0 
o
C
 
and 2 hours at room temperature. The reaction was 
evaporated to dryness via nitrogen stream and the remaining volatiles were removed by 
coevaporation with CH2Cl2 and diethyl ether. The product was dried under vacuum to 
afford compound II-5 in 95 % yield. Compound II-5 was used without further 
purification. Compound II-5 exists in solution as a pair of slowly exchanging rotamers; 
signals attributed to major (ma.) and minor (min.) rotamers are designated. 
1
H-NMR ( 
DMSO-d6, 400 MHz): δ 11.91 (s, 1H), 10.84 (s, 1H), 8.62 (d, J = 6 Hz, 2H), 8.14 (s, ma., 
0.62H), 8.08 (s, min., 0.40H), 8.06-7.25 (m, 16H), 4.92 (s, ma., 1.67H), 4.72 (s, min., 
1.33H), 4.32 (s, min., 0.61H), 4.07 (s, ma., 1.02H), 4.35-4.10 (m, 3H, CH2), 3.48 (m, 1H, 
CH2), 3.41 (m, 1H, CH2), 3.30 (m, 1H, CH2), 3.15 (m, 1H, CH2). 
13
C-NMR (DMSO-d6, 
400 MHz): δ 170.7, 170.4, 167.4, 167.0, 159.7, 158.5, 156.4, 156.3, 150.1, 143.8, 143.2, 
140.7, 139.4, 135.6, 127.6, 127.3, 127.0, 125.1, 124.8, 124.4, 120.1, 119.2, 114.7, 113.6, 
109.6, 65.6, 65.4, 48.6, 47.7, 46.7, 37.9, 26.8. HRMS (EI): calcd. For C38H33N6O7 [M + 
H]
+
 685.2411, found 685.2427. 
PNA oligomer: HRMS (ESI) m/z; found 4314.7836 [M + H]
+
 (calculated 4314.7713 for 
C185H228N76O50). 
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Chapter 3  
3 Fluorescent Adenosine Analogs: Synthesis and 
Photophysical Evaluation of Novel Fluorescent 7-
Substituted 7-Deazaadenosine Analogs 
3.1 Introduction 
2-Aminopurine nucleoside, a highly fluorescent isomer of adenosine, has been one of the 
most utilized adenosine analogs for the past forty years.
1
 However, this compound does 
not possess ideal properties for studying nucleic acids. For instance, 2-aminopurine 
nucleoside (2-AP), suffers dramatically reduced emission once incorporated into single-
stranded oligonucleotides and further yet upon duplex formation.
1
 This leaves relatively 
weak emission for studying the structure and dynamics of duplex species.  Therefore 
recent developments have sought to overcome the limitations of 2-AP.  
Although adenosine analogs may be substituted at various positions,
2
 this chapter will 
specifically focus on fluorescent adenosine analogs which are capable of Watson-Crick 
hydrogen bonding and are substituted at the 7-position with various alkynes. The benefit 
of substitution at the 7-position of the 7-deazapurine is that large groups can be 
accommodated in the major groove of resultant duplexes.
3
 
 Background on Adenosine Analogs Substituted at the 7-3.1.1
position 
Seela and co-workers have synthesized a small library of fluorescent 7-deazaadenosine 
nucleobase analogs via attachment of various alkynes to the 7-position via the 
Sonogashira reaction.
4-8
 Synthesis of the 7-substituted-7-deaza-2’-deoxyadenosines 
began with the iodination of the commercially available starting material 6-chloro-7-
deazapurine III-1. Compound III-1 was suspended in anhydrous dichloromethane, 
treated with N-iodosuccinimide and stirred at room temperature for 30 minutues to afford 
6-chloro-7-iodo-7-deazapurine, III-2, in 80 % yield (scheme 4). Compound III-2 was 
then suspended in acetonitrile and reacted with 1-chloro-3,5-di-O-toluoyl-2-deoxy-D-
ribofuranose in the presence of KOH and the phase transfer catalyst tris[2-(2-
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methoxyethoxy)ethyl]amine (TDA-1) to obtain the glycosylated product III-3 in 65 % 
yield. Next compound III-3 was deprotected by treatment with a saturated solution of 
NH3/MeOH to give compound III-4 in 63 % yield. Installation of the amino group was 
accomplished by reacting compound III-4 with a 25 % aqueous NH3/1,4-dioxane 
solution and heating the mixture to 110 
o
C for 15 h (sealed vial) to obtain compound III-
5 in 70 % yield. With compound III-5 in hand, a variety of 7-substituted 7-deaza-2’-
deoxyadenosines where synthesized by reacting compound III-5 with a range of different 
alkynes under Sonogashira conditions. 
 
Scheme 4: Synthesis of 7-substituted-7-deazaa-2’-deoxydenosine analogs. 
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Fluorescence quantum yields in H2O of the various 7-substituted-7-deazaadenosine 
analogs reported by Seela et al. range from 0.002 – 0.27 and the fluorescence lifetimes 
range from < 0.2 – 7.98 ns.4-8 Although many of these modified nucleobases exhibit 
fairly large Stoke shifts, a drawback associated with these fluorescent analogs is that their 
absorption wavelength maxima range from 270 – 320 nm. The shorter wavelengths 
substantially overlaps with the excitation wavelength of the natural nucleobases which 
implies that selective excitation of the modified nucleobases will not be possible in all 
cases and there exists the hazard of photochemical damage to the nucleic acids.  
One particular compound, 7-deaza-7-(hex-1-ynyl)-2’-deoxyadenosine, has been further 
investigated by Seela et al. This modified nucleobase exhibits an absorption maximum at 
280 nm and an emission wavelength maximum at 397 nm in H2O.
4-8
 Additionally the 
fluorescence quantum yield and fluorescence lifetime of 7-deaza-7-(hex-1-ynyl)-2’-
deoxyadenosine is 0.27 and 5.8 ns respectively.
4-8
 Furthermore, Seela and co-workers 
have demonstrated that the lipophilic hexynyl residue of 7-deaza-7-(hex-1-ynyl)-2’-
deoxyadenosine stabilizes oligonucleotide duplex structure and that stabilization occurs 
with both self-complementary and non-self-complementary oligonucleotide duplexes.
4-8 
In 2004, Saito and co-workers developed a tethered pyrene adenosine analog, 7-deaza-7-
(1-pyrenecarboxamido)propyl-2’-deoxyadenosine (Apy).9 The first step in the synthesis 
entailed a Sonogashira cross coupling reaction between 7-deaza-7-iodo-2’-
deoxyadenosine, which was prepared according to Seela’s method, and a pyrene 
substituted propargyl amine using Pd(PPh3)4 as the catalyst to afford compound III-6 
(Scheme 5). Compound III-6 was then hydrogenated using 10 % Pd/C in MeOH to 
obtain compound III-7. The next steps entailed protection of the exocyclic amino group 
of compound III-7 using N,N-dimethylformamide dimethylacetal to give compound III-8 
and protection of the 5’-hydroxyl group with 4,4’-dimethoxytrityl to obtain compound 
III-9. Lastly compound III-9 was converted to phosphoramidite III-10 using 2-
cyanoethyl-bis-diisopropylphosphoramidite. Compound III-10 was then oligomerized 
using an automated DNA synthesizer. 
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The authors did not report the spectroscopic properties of the monomer, rather they 
showed that this fluorescent modification exhibited a  fluorescence quantum yield of 
0.064, in the single strand 5’-d(CGCAATApyTAACGC)-3’.9 The corresponding Apy-C, 
A
py
-G and A
py
-A mismatched duplexes  showed  fluorescence quantum yields of 0.097, 
0.098 and 0.054 respectively.
9
 Interestingly the fluorescence quantum yield of the fully 
complementary A
py
-T duplex was significantly lower, 0.006, than the single strand or the 
mismatched duplexes. The authors hypothesized that the observed fluorescence 
quenching of the matched duplex was due to intercalation of pyrene into the duplex.
9
 
Molecular modelling studies supported this hypothesis that pyrene was intercalated into 
the duplex, resulting in duplex stabilization.
9
 The authors have thus developed a probe 
that can clearly distinguish thymine in a DNA-DNA duplex. 
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Scheme 5: Synthesis of 7-deaza-7-(1-pyrenecarboxamido)propyl-2’-deoxyadenosine. 
In 2008, Hocek and co-workers reported on the synthesis and photophysical properties of 
7-deaza-2’-deoxyadenosine derivatives bearing bipyridine ligands and their Ru(II)-
complexes.
10-11
 Synthesis of compounds III-11 and III-12 was accomplished via aqueous 
phase Sonogashira cross-coupling reactions between the corresponding Ru-containing 
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acetylene and 7-iodo-7-deaza-2’-deoxyadenosine using palladium/triphenylphosphine-
3,3′,3′′-trisulfonic acid trisodium salt (TPPTS) as the catalyst (scheme 6). 
These Ru(II)-complexes showed rather weak red luminescence.
10
 The fluorescence 
quantum yields in acetonitrile ranged from 2.1 to 289 x 10
-4
.
10
 Although the authors have 
not yet included compound III-11 into oligonucleotides, they did prepare the 
corresponding triphosphate of compound III-12 and incorporated this modification into 
oligonucleotides that were used for SNP detection.
11
 
 
Scheme 6: Synthesis of 7-deazaadenosine nucleosides bearing Ru(II) complexes. 
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A recent contribution to this class of nucleobases was made by Saito and co-workers 
where they synthesized fluorescent environmentally sensitive 7-deaza-2’-deoxyadenosine 
derivatives such as ethynylanthracene and ethynylnaphthalene substituted derivatives.
12
 
Synthesis of the ethynyl-cyanonaphthalene substituted derivative was accomplished via a 
Sonogashira reaction between 7-iodo-7-deaza-2’-deoxyadenosine and 2-ethynyl-
cyanonaphthalene to afford compound III-13 in high yield (scheme 7). Compound III-13 
was then treated with dimethylformamide dimethyl acetal in order to protect the 
exocyclic amino group on the purine core. The 5’-hydroxyl group of compound III-14 
was then protected using dimethoxytrityl chloride to obtain compound III-15 in 
quantitative yield. Lastly compound III-15 was converted to the phosphoramidite III-16 
using 2-cyanoethyldiisopropylchlorophosphoramidite and triethylamine. Although 
scheme 6 specifically shows the synthesis of compound III-16, other derivatives were 
also synthesized using the same protocol.
12
 
Interestingly the cyano-naphthylethynylated 7-deaza-2’-deoxyadenosine exhibited 
remarkable solvatochromatic properties, for instance in chloroform this compound 
exhibits an absorption maxium at 345 nm and an emission maximum at 423 nm whereas 
in acetonitrile the emission maximum shifts to 494 nm, Δλ = 71 nm.12 Furthermore, upon 
incorporation of this modification into oligodeoxynucleotides, the authors found that this 
analog forms stable base pairs with both thymine and cytosine which is accompanied by a 
change in fluorescence intensity.
12
 When the opposite base in the complementary strand 
is thymine, strong fluorescence was observed at 468 nm.
12
 When the opposite base in the 
complementary strand is cytosine, stronger fluorescence intensity was observed and the 
emission maximum was blue-shifted to 446 nm.
12
 Fluorescence emission of the single 
strand was weak and appeared at 461 nm.
12
 The authors do not show the fluorescence 
emission when adenine or guanine are opposite the modification. The authors proposed 
that the change in fluorescence intensity and emission wavelength observed with thymine 
and cytosine opposite the fluorescent adenine moiety was caused by a change in the local 
environment near the solvatochromatic adenine moiety.
12
  Thus these 7-deazaadenosine 
analogs exhibit desirable photophysical characteristics which bode well for their use in 
studying nucleic acids.  
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Scheme 7: Synthesis of ethynylnaphthalene substituted 7-deaza-2’-deoxyadenosine. 
This chapter focuses on the synthesis and photophysical characterization of novel 
fluorescent 7-deaza-2´-deoxyadenosines analogs, in order to evaluate their potential for 
use as fluorescent probes in DNA oligonucleotides. The photophysical properties of these 
analogs were studied in three different solvents, H2O, EtOH and 1,4-dioxane, to study 
their microenvironment sensitivity. The photophysical properties that were investigated 
include the wavelength of absorption (λab), the wavelength of fluorescence (λfl), the molar 
extinction coefficient (ε), the fluorescence quantum yield (ΦF), and the Stokes shift. 
Moreover, the brightness values of these fluorophores are also reported. The brightness of 
a fluorophore is the product of the molar extinction coefficient and the fluorescence 
quantum yield. Brightness values are useful for comparing the utility of two fluorophores 
with similar fluorescence quantum yields but strikingly different molar extinction 
coefficients.    
48 
 
The adenosine analogs were synthesized via the Sonogashira cross-coupling reaction of 
9-ethynylphenanthrene, 2-ethynyl-6-methoxynaphthalene, and 1-ethynylpyrene to 7-
iodo-7-deaza-2´-deoxyadenosine (III-20), in order to produce three fluorescent 7-deaza-
2´-deoxyadenosines containing rigid, polyaromatic pendant fluorophores. 9-
ethynylphenanthrene and 1-ethynylpyrene were selected as alkynes due to the rigidity 
and moderate to high fluorescence quantum yields of phenanthrene (0.13 in EtOH)
13
 and 
pyrene (0.65 in EtOH).
13
 2-ethynyl-6-methoxynaphthalene was selected in order to 
investigate the effect of the electron-donating methoxy group on the fluorescence 
quantum yield.  
3.2 Results and Discussion 
The synthesis began with chlorination of commercially available 7-deaza-6-
hydroxypurine using POCl3,
14
 to afford the desired compound III-17 in reasonable 50 % 
yield (scheme 8). Compound III-17 was then iodinated at the 7 position by treatment 
with NIS in DMF
15
 to obtain compound III-18 in high yield. Next compound III-18 was 
deprotonated with NaH in acetonitrile followed by the addition of 1-chloro-2-deoxy-3,5-
di-O-ρ-chlorobenzoyl-α-D-ribose to afford exclusively the β-anomer of the glycosylated 
product,
16
 compound III-19, in 60 % yield. Next, installation of the exocyclic amino 
group and deprotection of the ester protecting groups was accomplished in one step via 
treatment of compound III-19 with a saturated NH3/MeOH solution
17
 to afford 
compound III-20 in 80 % yield. Lastly compound III-20 was reacted with various 
alkynes under Sonogashira conditions
18
 to obtain the desired 7-substituted-7-
deazaadenosine nucleosides III-21 – III-23. 
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Scheme 8: Synthesis of novel fluorescent 7-deaza-2’-deoxyadenosine analogs. 
 Photophysical Evaluation 3.2.1
The photophysical properties of A
pyr
, A
mon
, and A
phen
 were evaluated in dioxane, ethanol, 
and water, in order to study how the fluorescence properties of the products vary across 
solvents of different polarities. Based on the solvent’s dielectric constant (ε), dioxane 
represents a non-polar solvent (ε = 2), EtOH represents a polar solvent (ε = 24), and 
water represents a highly polar solvent (ε = 80).19 The results obtained are presented in 
Table 6 and the excitation-emission profiles are shown in Figures 16-18.  
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Analog 
 
Solvent 
λab 
(nm)
 
λfl 
(nm) 
Stokes 
Shift (nm) 
ε 
(×10
3
 M
-
1
cm
-1
) 
 
ΦF 
Brightness
 
(×10
3
 M
-
1
cm
-1
) 
 dioxane 319 370 51 12.5 ± 0.2 0.15 1.9 
A
mon EtOH 318 370 52 8.3 ± 0.4 0.24 2.0 
 H2O 317 435 118 2.2 ± 0.2 0.02 0.0 
 dioxane 336 390 54 16.1 ± 0.3 0.14 2.3 
A
phen EtOH 332 392 60 15.0 ± 0.6 0.08 1.2 
 H2O 335 444 109 6.2 ± 0.5 0.02 0.1 
 dioxane 367 429 62 27.1 ± 1.6 0.52 14.1 
A
pyr EtOH 366 432 66 39.4 ± 1.0 0.43 16.9 
 H2O 364 474 110 18.7 ± 0.6 0.01 0.2 
Table 6: Photophysical properties of fluorescent 7-deaza-2’-deoxyadenosines. 
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Figure 16: Excitation emission profiles of A
mon
 in dioxane (top left), EtOH (top 
right) and H2O (bottom left). 
 
   
            
 
 
 
 
Figure 17: Excitation emission profiles of A
phen
 in dioxane (top left), EtOH (top 
right) and H2O (bottom left). 
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All three adenosine analogs exhibited red-shifted absorption wavelengths compared to 
the naturally occurring nucleobases. In addition, the absorption wavelengths were found 
to increase with the number of polyaromatic rings, such that A
pyr
 had the most red-shifted 
absorption wavelengths (λab = 364-367 nm), followed by A
phen
 (λab = 332-336 nm), and 
A
mon
 (λab = 317-319 nm). This trend is a direct consequence of increased conjugation, 
which decreases the energy gap between the ground state and the excited state, allowing 
for wavelengths of lower energy to induce electronic transitions.
20
  
Similarly, A
pyr
 exhibited the most red-shifted fluorescence wavelengths (λfl = 429, 432, 
474 nm), followed by A
phen
 (λfl = 390, 392, 444 nm), and A
mon
 (λfl = 370, 370, 435 nm). 
The emission wavelengths in water for all three analogs were significantly red-shifted 
compared to emission wavelengths in ethanol and dioxane. Thus, all three analogs show 
solvatofluorochromicity in water, relative to ethanol and dioxane. However, all three 
analogs did not display significant solvatofluorochromicity with respect to their emission 
wavelengths in ethanol versus dioxane. Only a slight increase in the emission wavelength 
was observed for A
pyr
 and A
phen
 in ethanol, relative to dioxane. This result suggests that 
Figure 18: Excitation emission profiles of A
pyr
 in dioxane (top left), EtOH (top 
right) and H2O (bottom left). 
 
53 
 
highly polar aqueous solvents stabilize the excited states to a greater extent than organic 
solvents of both high and low polarity. In addition, this result also indicates that 
polyaromatic substituents containing conjugated electron-donating groups do not enhance 
the solvatofluorochromicity of 7-deaza-2´-deoxyadenosines, as was found with 
conjugated electron-withdrawing groups.
12
  
Due to the stabilizing effect of solvent polarity on the excited states of fluorophores, all 
three analogs had Stokes shifts that increased with solvent polarity. In addition, the 
Stokes shifts were found to increase with the number of aromatic rings present, such that 
A
pyr
 had the largest Stokes shifts (62, 66, 110 nm), followed by A
phen
 (54, 60, 109 nm), 
and A
mon
 (51, 52, 118 nm). However, one interesting exception to this trend was that 
A
mon 
displayed a larger Stokes shift in water than both A
pyr
 and A
phen
. This effect is 
believed to be a direct consequence of the presence of the methoxy group, since 
fluorophores of higher polarity are more sensitive to the stabilizing effects of polar 
solvents.
20
 
The molar extinction coefficients were also found to increase significantly with the size 
of the polyaromatic fluorophore. This trend is attributed to the fact that larger 
polyaromatic substituents provide a greater conjugated surface area for π-π* transitions to 
occur.
20
 Considering the impact of the molar absorption coefficient on fluorophore 
brightness, larger molar extinction coefficients are desirable. Thus, A
pyr
 (ε = 18.7, 27.1, 
39.4 ×103 M
-1
 cm
-1
) was found to be the most efficient at absorbing light, followed by 
A
phen
 (ε = 6.2, 15.0, 16.1 ×103 M-1 cm-1), and Amon (ε = 2.2, 8.3, 12.5 ×103 M-1 cm-1). 
Due to the high fluorescence quantum yield of pyrene (Φf in ethanol = 0.65),
12
 A
pyr
 was 
expected to display desirable fluorescence properties. These expectations were indeed 
met, as A
pyr
 displayed high fluorescence quantum yields in dioxane, Φf = 0.52, and 
ethanol, Φf = 0.43. Conversely, A
pyr
 had a dramatically reduced fluorescence quantum 
yield in water, Φf = 0.01. These large differences in quantum yield are attractive because 
they enable A
pyr
 to be used as an environmentally sensitive fluorescent probe across all 
three solvents. In addition, when the molar extinction coefficients of A
pyr
 are factored 
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into the equation, its remarkable brightness measurements (16.9, 14.1, 0.2) indicate that 
A
pyr
 would make a highly efficient and highly sensitive fluorescence probe. 
Similarly, due to the moderate fluorescence quantum yield of phenanthrene (Φf in ethanol 
= 0.13),
13
 A
phen
 was expected to display useful fluorescence properties. Overall, A
phen
 
displayed modest fluorescence quantum yield differences across dioxane Φf = 0.14, 
ethanol Φf = 0.08, and water Φf = 0.02. Although it was expected that A
phen
 would display 
lower quantum yields than A
pyr
, it was interesting to find that A
phen
 also displayed lower 
fluorescence quantum yields than A
mon
, despite the inherent benefit of increased 
aromaticity. These moderate fluorescence quantum yields significantly impacted the 
brightness measurements observed for A
phen
 (2.3, 1.2, 0.1 ×10
3
 M
-1
 cm
-1
), despite having 
high molar absorptivity. Nevertheless, A
phen
 displays fair potential for use as an 
environmentally sensitive fluorescence probe. 
Lastly, due to previous reports that conjugated electron-donating groups can be used to 
increase fluorescence quantum yields,
4
 A
mon
 was expected to show a marked increase in 
quantum yields, relative to the 2-ethynylnaphthalene derivative.
12
 A
mon
 exhibited its 
largest fluorescence quantum yield in ethanol Φf = 0.24, followed by dioxane ΦF = 0.15, 
and water, ΦF = 0.01. These moderately high fluorescence quantum yields had a positive 
effect on fluorophore brightness (2.0, 1.9, 0.0 ×10
3
 M
-1
 cm
-1
), compensating for the 
compound’s relatively low molar absorptivity. Thus, Amon displays fair potential for use 
as an environmentally sensitive fluorescent probe across all three solvents. In addition, 
the 2-ethynylnaphthalene derivative was synthesized and photophysically characterized 
by Saito and co-workers.
12
 The authors reported similar spectral characteristics to A
mon
 in 
ethanol, λab = 318 nm, λfl = 371 nm, however the fluorescence quantum yield in ethanol 
was significantly lower, Φf = <0.01.
12
 This result confirms the ability of conjugated 
electron-donating groups to enhance the fluorescence quantum yield of 7-deaza-2´-
deoxyadenosines. 
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3.3 Conclusion 
In conclusion, three novel fluorescent 7-deaza-2´-deoxyadenosine derivatives containing 
rigid, polyaromatic fluorophores were successfully synthesized via the Sonogashira 
cross-coupling reaction of 7-iodo-7-deaza-2´-deoxyadenosine (III-20) with 1-
ethynylpyrene, 2-ethynyl-6-methoxynaphthalene, and 9-ethynylphenanthrene. These 7-
deaza-2´-deoxyadenosine analogs were photophysically characterized in dioxane, EtOH, 
and H2O in order to evaluate their potential for use as environmentally sensitive 
fluorescent probes. 
Among them, A
pyr
 showed the most promise, due to it’s red-shifted absorption 
wavelengths (λab = 364, 366, 367 nm), red-shifted emission wavelengths (λfl = 429, 432, 
474 nm), large molar extinction coefficients (ε = 18.7, 27.1, 39.4 ×103 M-1 cm-1), high 
fluorescence quantum yields in dioxane (ΦF = 0.52) and EtOH (ΦF = 0.43), and dramatic 
decrease in fluorescence quantum yield in H2O (ΦF = 0.01). Such sizable differences in 
quantum yields and molar absorption coefficients allow for A
pyr
 to be detected with high 
sensitivity across all three solvents, as illustrated by its large brightness measurements 
(16.9, 14.1, 0.2 ×10
3
 M
-1 
cm
-1
). These characteristics, in conjunction with the benefit that 
large substituents at the 7-position of the 7-deazapurine can be accommodated in the 
major groove of resultant duplexes,
3
 suggests that A
pyr
 has considerable potential for use 
as an environmentally sensitive fluorescent probe. 
In addition, A
mon
 and A
phen
 were found to display modest potential for use as 
environmentally sensitive fluorescent probes. Both A
mon
 and A
phen
 had red-shifted 
absorption and emission wavelengths above those of the naturally occurring nucleobases. 
However, A
mon
 was the least red-shifted of all three analogues. The lower molar 
absorptivity (ε = 2.2, 8.3, 12.5 ×103 M-1 cm-1) but higher quantum yields (ΦF = 0.24, 0.15, 
0.01) of A
mon
, versus the lower quantum yields (ΦF = 0.14, 0.08, 0.02) but higher molar 
absorptivity (ε = 6.2, 15.0, 16.1 ×103 M-1 cm-1) of Aphen, combined to produce comparable 
brightness measurements. The relatively low brightness measurements observed for A
mon
 
(2.0, 1.9, 0.0 ×10
3
 M
-1 
cm
-1
) and A
phen
 (2.3, 1.2, 0.1 ×10
3
 M
-1 
cm
-1
) hamper their ability to 
be detected with high sensitivity in the applications of interest. 
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Lastly, the fluorescence quantum yield of the 2-ethynyl-6-methoxynaphthalene derivative 
(A
mon
) was found to increase dramatically (EtOH: ΦF = 0.24) from that of the 2-
ethynylnaphthalene derivative (EtOH: ΦF = <0.01).
12
 This result confirms the ability of 
polyaromatic substituents containing conjugated electron-donating groups to increase the 
fluorescence quantum yields of 7-deaza-2´-deoxyadenosines. 
3.4 Future Work 
The next phase of this research project would be to incorporate A
pyr
 into an 
oligonucleotide sequence for use as an environmentally sensitive fluorescent probe. This 
would entail protection of the exocyclic amino group of A
pyr
 using dimethylformamide 
dimethyl acetal
12
 (Scheme 9). Next the 5’-hydroxyl group will be protected by treatment 
with dimethoxytrityl chloride and pyridine.
12
 Lastly, phosphoramidite synthesis will be 
accomplished using 2-cyanoethyldiisopropylchlorophosphoramidite and 
trimethylamine.
12
 This will yield a monomer suitable for incorporation into an 
oligonucleotide via automated DNA synthesis. Based on the promising photophysical 
properties of A
pyr
, we anticipate that this analog will act as a useful fluorescent probe to 
study nucleic acid microenvironment.   
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Scheme 9: Proposed synthesis of A
pyr
 DNA monomer. 
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3.5 Experimental 
4-chloro-7H-pyrrolo[2,3-d]pyrimidine (III-17): 
                                                                 
7H-pyrrolo[2,3-d]pyrimidin-4-ol (4.01 g, 29.7 mmol) was suspended in 45 mL of POCl3 
and refluxed for 1 hour. The solution was cooled to room temperature and excess POCl3 
was removed by rotary evaporation. A mixture of dichloromethane (600 mL) and ice 
water (200 mL) was then added to the dark-brown residue and stirred for 24 hours, or 
until the dark-brown residue was completely dissolved. The aqueous layer was then 
neutralized by adding increments of a saturated sodium bicarbonate solution (3 × 300 
mL). The organic layer was collected, dried over MgSO4, and gravity filtered. The 
product was dried by rotary evaporation, producing a pale yellow solid (2.35 g, 52%). 
1
H-
NMR ( DMSO-d6, 400 MHz): δ = 12.57 (br s, 1 H), 8.59 (s, 1 H), 7.69 (d, J = 2.3 Hz, 1 
H), 6.61 (d, J = 2.3 Hz, 1 H); 
13
C-NMR (DMSO-d6, 400 MHz): δ = 151.75, 150.41, 
150.26, 128.35, 116.52, 98.76; HRMS (EI): calcd. for C6H3ClN3[M]
+
 153.0094, found 
153.0090.  
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4-chloro-5-iodo-7H-pyrrolo[2,3-d]pyrimidine (III-18): 
                                                                   
Compound III-17 (2.33 g, 15.2 mmol) was dissolved in 54 mL of DMF, followed by the 
addition of NIS (3.58 g, 15.9 mmol). The reaction was stirred at room temperature for 2 
hours. The solvent was removed by rotary evaporation and 60 mL of ice water was added 
to the orange residue. The precipitate was then collected by vacuum filtration, washed 
with ice water (3 × 15 mL), and concentrated in vacuo. The product was obtained as a 
pale brown solid (3.75 g, 88%). 
1
H-NMR (DMSO-d6, 400 MHz): δ = 12.94 (br s, 1 H), 
8.59 (s, 1 H), 7.93 (s, 1 H). 
13
C-NMR (DMSO-d6, 400 MHz): δ = 151.95, 151.18, 150.93, 
134.31, 116.23, 52.12; HRMS (EI): calcd. for C6H3ClIN3[M]
+
 278.9060, found 278.9052. 
(2R,3S,5R)-5-(4-chloro-5-iodo-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-2-((4-
chlorobenzoyloxy)methyl)tetrahydrofuran-3-yl 4-chlorobenzoate (III-19):  
                                          
Compound III-18 (1.00 g, 3.60 mmol) was dissolved in 28 mL of anhydrous acetonitrile, 
followed by the addition of sodium hydride (0.15 g, 6.6 mmol). The reaction was stirred 
at room temperature under an atmosphere of nitrogen for 30 minutes. Next, 1-chloro-2-
deoxy-3,5-di-O-ρ-chlorobenzoyl-α-D-ribose (1.57 g, 3.6 mmol) was added to the reaction 
and the mixture was stirred at 50°C for 2 hours. The solvent was removed by rotary 
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evaporation and the crude product was purified by flash chromatography eluting with 2 
% acetone in toluene to afford compound III-19 as a pale yellow solid (1.36 g, 57%). 
1
H-
NMR (CDCl3, 400 MHz): δ = 8.61 (s, 1H), 8.10 – 7.90 (m, 4H), 7.55 (s, 1H), 7.47 (m, 4 
H), 6.77 (t, J = 4.0 Hz, 1H), 5.76 (m, 1H), 4.80 – 4.50 (m, 3H), 2.90 – 2.70 (m, 2H). 13C-
NMR (CDCl3, 400 MHz): δ = 165.0, 164.9, 152.8, 150.9, 150.4, 140.1, 139.9, 131.2, 
131.0, 130.5, 128.9, 128.8, 127.5, 127.2, 117.4, 84.3, 82.3, 75.0, 63.9, 52.9, 37.9. HRMS 
(EI): calcd. for C25H17Cl3IN3O5[M]
+
  670.9278, found 670.9546. 
(2R,3S,5R)-5-(4-amino-5-iodo-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-2-
(hydroxymethyl)tetrahydrofuran-3-ol (III-20):  
                                                       
Compound III-19 (0.55 g, 0.80 mmol) was added to a thick-walled round bottom flask 
and suspended in 50 mL of methanol. The suspension was cooled to 0 
o
C followed by the 
addition of ammonia, which was bubbled into the suspension for 30 minutes. The 
reaction vessel was tightly sealed and the reaction was stirred at 100 
o
C for 24 hours. The 
solvent was removed by rotary evaporation and the crude product was purified by flash 
chromatography on SiO2, eluting with 10 % methanol in dichloromethane. The product 
was obtained as a white solid in 80 % yield. 
1
H NMR (DMSO-d6, 400 MHz): δ = 8.09 (s, 
1H), 7.65 (s, 1H), 6.48 (m, 1H), 5.25 (d, J = 6.0 Hz, 1H), 5.02 (t, J = 6.0 Hz, 1H), 4.32 
(m, 1H), 3.80 (m, 1H), 3.56 (m, 2H), 2.47 (m, 1H), 2.17 (m, 1H); 
13
C NMR (DMSO-d6, 
400 MHz): δ = 157.3, 152.1, 150.0, 126.9, 103.3, 87.5, 83.1, 71.1, 62.0, 52.0, C(2’) 
overlapped with DMSO; HRMS (EI): m/z calcd for C11H13 IN4O3: 376.0032; found: 
376.0025. 
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7-(1-ethynylpyrene)-7-deaza-2’-deoxyadenosine Apyr (III-21):  
                                                  
Compound III-20 (100 mg, 0.26 mmol) was dissolved in dry, deoxygenated DMF (2.0 
mL) to which CuI (10 mg, 0.052 mmol), Et3N (0.075 mL, 0.52 mmol), 1-ethynylpyrene 
(240 mg, 1.04 mmol) and Pd(PPh3)4 (31 mg, 0.026 mmol) were sequentially added. The 
reaction mixture was stirred in the dark at 60 
o
C for 24 hours. The solvent was removed 
in vacuo and the residue diluted with 15 mL of dichloromethane. The organic layer was 
washed with 3 % EDTA solution (3 x 5 mL) and brine (3 x 5 mL). The organic layer was 
dried and concentrated in vacuo. The crude product was purified by FCC eluting with 10 
% methanol in dichloromethane to afford compound III-21 in 33 % yield. 
1
H-NMR 
(DMSO-d6, 600 MHz): δ 8.59 (d, J = 12.0 Hz, 1H), 8.49 – 8.00 (m 10H), 6.58 (m, 1H), 
5.31 (d, J = 6.0 Hz, 1H), 5.11 (t, J = 6.0 Hz, 1H), 4.41 (m, 1H), 3.88 (m, 1H), 3.75 - 3.50 
(m, 2H), 2.58 (m, 1H), 2.27 (m, 1H). 
13
C-NMR (DMSO-d6, 400 MHz): δ 157.7, 152.8, 
149.5, 131.0, 130.8, 130.7, 130.4, 129.5, 128.7, 128.2, 127.3, 127.2, 126.3, 126.0, 125.9, 
125.8, 124.7, 123.6, 123.4, 117.1, 102.1, 94.9, 89.9, 88.9, 87.6, 83.2, 70.9, 61.9, 54.9, 
C(2’) overlapped with DMSO; HRMS (EI): m/z calcd for C29H22N4O3: 474.1692; found: 
474.1697. 
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7-(2-ethynyl-6-methoxynaphthalene)-7-deaza-2’-deoxyadenosine Amon (III-22):  
                                                 
Compound III-20 (85 mg, 0.20 mmol) was dissolved in dry, deoxygenated DMF (1.8 
mL) to which CuI (8 mg, 0.042 mmol), Et3N (0.060 mL, 0.43 mmol), 2-ethynyl-6-
methoxynaphthalene (163 mg, 0.80 mmol) and Pd(PPh3)4 (24 mg, 0.021 mmol) were 
sequentially added. The reaction mixture was stirred in the dark at 60 
o
C for 24 hours. 
The solvent was removed in vacuo and the residue diluted with 15 mL of 
dichloromethane. The organic layer was washed with 3 % EDTA solution (3 x 5 mL) and 
brine (3 x 5 mL). The organic layer was dried and concentrated in vacuo. The crude 
product was purified by FCC eluting with 10 % methanol in dichloromethane to afford 
compound III-22 in 33 % yield. 
1
H-NMR (DMSO-d6, 600 MHz): δ 8.16 (s, 1H), 8.12 (s, 
1H), 7.89 (s, 1H), 7.90 -7.82 (m, 1H), 7.60 (dd, J1 = 12.0 Hz, J2 = 6.0 Hz, 1H), 7.55-7.37 
(m, 1H), 7.22 (dd, J1 = 12.0 Hz, J2 = 6.0 Hz, 1H), 6.53 (m, 1H), 5.29 (m, 1H), 5.07 (t, J = 
6.0 Hz, 1H), 4.37 (m, 1H), 3.88 (s, 3H), 3.83 (m, 1H), 3.59 (m, 1H), 3.57 (m, 1H), 2.23 
(m, 1H); 
13
C NMR (DMSO-d6, 400 MHz): δ = 158.2, 157.7, 149.5, 138.5, 133.9, 129.4, 
128.2, 119.5, 117.4, 102.2, 95.0, 91.8, 87.9, 82.7, 71.08, 62.0, 51.5, 50.0, C(2’) 
overlapped with DMSO; HRMS (EI): m/z calcd for C24H22N4O4: 430.1641; found: 
430.1636. 
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7-(9-ethynylphenanthrene)-7-deaza-2’-deoxyadenosine Aphen (III-23):  
                                                    
Compound III-20 (100 mg, 0.27 mmol) was dissolved in dry, deoxygenated DMF (2.0 
mL) to which CuI (10 mg, 0.054 mmol), Et3N (0.075 mL, 0.52 mmol), 9-
ethynylphenanthrene (215 mg, 1.08 mmol) and Pd(PPh3)4 (31 mg, 0.026 mmol) were 
sequentially added. The reaction mixture was stirred in the dark at 60 
o
C for 24 hours. 
The solvent was removed in vacuo and the residue diluted with 15 mL of 
dichloromethane. The organic layer was washed with 3 % EDTA solution (3 x 5 mL) and 
brine (3 x 5 mL). The organic layer was dried and concentrated in vacuo. The crude 
product was purified by FCC eluting with 10 % methanol in dichloromethane to afford 
compound III-23 in 55 % yield. 
1
H-NMR (DMSO-d6, 600 MHz): δ 8.93-8.86 (m, 2H), 
8.45 (m, 1H), 8.31 (s, 1H), 8.20 (s, 1H), 8.08 (s, 1H), 8.04 (d, J = 6.0 Hz, 1H), 7.81-7.70 
(m, 4H), 6.56 (m, 1H), 5.30 (d, J = 6.0 Hz, 1H), 5.10 (t, J = 6.0 Hz, 1H), 4.39 (m, 1H), 
3.87 (m, 1H), 3.63 (m, 1H), 3.57 (m, 1H), 2.57 (m, 1H), 2.26 (m, 1H); 
13
C NMR 
(DMSO-d6, 400 MHz): δ = 157.6, 152.8, 149.5, 132.3, 131.7, 131.4, 130.7, 130.5, 130.2,  
129.6, 129.5, 128.5, 127.9, 127.5, 127.3, 122.9, 102.1, 94.6, 89.0, 87.6, 83.2, 70.9, 61.8, 
30.7, C(2’) overlapped with DMSO; HRMS (EI): m/z calcd for C27H22N4O3: 450.1692; 
found: 450.1685. 
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Chapter 4  
4 Fluorescent Adenine Analogs: Efforts Toward the 
Synthesis of a Novel Tricyclic 7-Deazaadenine 
4.1 Introduction:  
The objective of this research project was to synthesize a novel tricyclic adenine analog 
by extending the substrate scope of the Sonogashira cross-coupling/heteroannulation 
chemistry developed in the Hudson group
 
for cytidine analogs
1
 to adenine analogs 
(scheme 10).  
                         
Scheme 10: Expanding the substrate scope of the Sonogashira cross-
coupling/heteroannulation reaction developed for cytidine analogs to adenine 
analogs. 
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While we were exploring this chemistry for the synthesis of a novel tricyclic adenine 
analog, Wilhelmsson’s group reported the synthesis of a fluorescent, tetracyclic adenine 
analog.
2
 The synthesis was based on Matteucci’s method,3 and began with the 
condensation of 6-chloro-7-deaza-7-iodopurine with the chloro sugar using sodium 
hydride to yield the desired compound IV-1, predominantly the β anomer (scheme 11). 
The following step entailed a Stille coupling reaction between compound IV-1 and 
tributylstannyl-N-(Boc)aniline using Pd(PPh3)4, cesium fluoride and copper iodide to 
enhance the reaction rate.
4
 Ring closure to form compound IV-3 was achieved using a 
mixture of DABCO and DBU followed by deprotection of the Boc group using 25 % 
TFA in dichloromethane. Deprotection of the toluoyl group was then performed using a 
0.5 M solution of NaOMe in MeOH to yield the free nucleoside. Compound IV-4 was 
then treated with dimethoxytrityl chloride in pyridine to give compound IV-5. Lastly 
compound IV-5 was converted to the phosphoramidite monomer using Hunig’s base and 
2-cyanoethyl diisopropylchlorophosphoramidite. 
This tetracyclic adenosine analog exhibits an excitation wavelength maximum at 337 nm, 
which is extremely desirable for selective excitation, and an emission wavelength 
maximum at 457 nm.
2
 This molecule also displays a modest quantum yield in water of 
0.068.
2
  Upon incorporation into DNA this tetracyclic adenosine analog either increases 
or preserves duplex stability depending on the sequence.
2
 Furthermore this analog does 
not experience severe quenching upon oligomerization and can reach quantum yield 
values significantly higher than 2-aminopurine in certain sequences.
2
 Moreover this 
compound demonstrates highly specific base-pairing with thymine making it a potential 
probe for mismatch studies. 
The authors also examined at the quantum yields of DNA duplexes containing a 
tetracyclic adenosine mismatch as well as the corresponding matched duplexes. They 
observed that the quantum yield increased threefold for the mismatched sequences 
compared to the matched sequences.
2
 They also observed that the average quantum yield 
of tetracyclic adenine in single strands is higher or equal to their corresponding 
mismatched duplexes.
2
 Therefore, the authors suggest that the increase in quantum yield 
may be due to the weaker base pairing between tetracyclic adenine and the mismatched 
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bases.
2
 Thus leading to less extensive base stacking and an increased opening rate for the 
mismatched tetracyclic adenine base pairs compared to the tetracyclic adenine-thymine 
base pair.
2 
Scheme 11: Synthesis of a tetracyclic adenosine analog. 
Although the tetracyclic adenine analog and the tricyclic adenine analog have similar 
structural characteristics, there is a key structural difference between them. The 
tetracyclic adenine analog possesses a fused aromatic ring whereas the aromatic ring in 
the tricyclic adenine analog is attached through a carbon-carbon single bond between two 
sp
2
 hybridized carbon atoms. Wilhelmsson’s report on the tetracyclic adenine analog 
gave us confidence that similar types of heterocycles could be accessed, thus we decided 
to continue to pursue our investigation of the tricyclic adenine analog.  
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Our approach toward the tricyclic adenine analog is based on a sequential 
Sonogashira/cyclization methodology (Scheme 12). Matsuda and co-workers have 
previously reported the synthesis of 7-deazaadenine using this Sonogashira/cyclization 
reaction sequence.
5
 Thus, by extending this chemistry to the 7-deazaadenine scaffold, we 
envision the synthesis of a novel tricyclic adenine analog with variable substitution 
possible at R1 and R2 (Scheme 12).  
 
Scheme 12: Sequential Sonogashira/cyclization synthetic strategy toward a tricyclic 
adenine analog. 
                      
4.2 Results and Discussion 
Efforts toward the synthesis of a tricyclic adenine analog began with the iodination of 
4,6-diaminopyrimidine hemisulfate monohydrate to afford compound IV-7 in 81 % yield 
(scheme 13).
5
 The next step entailed a Sonogashira cross-coupling reaction between 
compound IV-7 and TMS acetylene. The catalyst system employed was (Ph3P)2PdCl2 
and CuI which gave rise to the cross coupled product compound IV-8 in 45 % yield.
5
 
Compound IV-8 was then cyclized by treatment with t-BuOK in NMP
5
 to afford the 7-
deazaadenine heterocycle, compound IV-9 in 86 % yield. 7-Deazaadenine was then 
iodinated at the 7-position using NIS in DMF
6
 to afford compound IV-10 in 40 % yield. 
Compound IV-10 was alkylated at N9 by treatment with NaH and ethyl bromoacetate in 
DMF
7
 to obtain the desired compound IV-11 in 66 % yield. Installation of the benzoyl 
group on the exocyclic amine of compound IV-11 was accomplished using benzoic 
anhydride and DMAP in acetonitrile
8
 to afford compound IV-12 in 60 % yield. Lastly, 
compound IV-12 was subjected to the Sonogashira cross-coupling/heteroannulation 
reaction conditions.
1
 However, unlike the cytidine scaffold, the 7-deazaadenine substrate 
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did not cyclize under these conditions to give a tricyclic adenine and the straight cross-
coupled product was isolated in 70 % yield. 
 
 
Scheme 13: Efforts toward the synthesis of a tricyclic adenine analog.  
Initial attempts at troubleshooting the Sonogashira/cyclization reaction on the adenine 
scaffold included carrying out the reaction at higher temperatures while holding all other 
reaction conditions constant (table 7). However, increased temperatures did not promote 
the cyclization reaction to occur and only the straight cross-coupled product was formed. 
The isolated product was analyzed by 
13
C-NMR and IR spectroscopy to determine the 
presence of an internal alkyne. The peak at 92.8 ppm in the 
13
C-NMR spectrum 
represents the alkyne carbons and the signal at 2150 cm
-1
 in the IR spectrum is indicative 
of an alkyne stretch. 
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Trial Temperature (
o
C) 
13
C-NMR signal 
(ppm) 
FTIR signal 
(cm
-1
) 
1 60 92.8 2150 
2 90 92.8 2150 
3 110 92.8 2150 
Table 7: Sonogashira/cyclization reaction at elevated temperatures. 
Since the problematic step was the cyclization reaction rather than the Sonogashira 
reaction, compound IV-13 was used as the substrate for the cyclization reaction using 
greater equivalents of CuI (table 8).
9
 Unfortunately, carrying out the cyclization reaction 
with 30 mol % of CuI resulted in unreacted starting material. Furthermore, increasing the 
amount of CuI to 50 mol % and allowing the reaction to proceed for 48 hours at 80 
o
C 
proved to be detrimental. TLC analysis of the reaction mixture showed many spots 
including a spot corresponding to the unreacted starting material. 
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Trial CuI (mol %) Reaction time (h) Result 
1 30 24 Unreacted starting 
material 
2 50 48 unreacted starting 
material + 
decomposition 
Table 8: Cyclization reaction attempts with increased amounts of CuI. 
The initial synthesis towards a tricyclic adenine analog was quite lengthy and some steps 
proceeded in low yield. This led to the search for a more efficient route to access these 
compounds. The improved synthesis began with the chlorination of the commercially 
available starting material, 7-deaza-6-hydroxypurine, using POCl3,
10 
which yielded 
compound IV-14 in a modest but useful 50 % yield (scheme 14). Next, the exocyclic 
amino group was installed by treating compound IV-14 with a saturated solution of 
ammonia in methanol to afford 7-deazaadenine in 75 % yield.
11
 7-deazaadenine was then 
iodinated at the 7-position by treatment with NIS in DMF
12
 to obtain the iodinated 
compound IV-10 in 40 % yield. Compound IV-10 was alkylated at N9 by treatment with 
NaH and t-butyl bromoacetate in DMF
7
 to afford the desired compound IV-15 in 60 % 
yield. Lastly the Sonogashira reaction was performed between compound IV-15 and 
phenyl acetylene.
1
 The catalyst system employed was Pd(PPh3)4 and CuI which gave rise 
to the cross coupled product compound IV-16 in 52 % yield. 
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Scheme 14: A more efficient route towards a tricyclic adenine analog. 
With the desired substrate in hand, the next step was to try the cyclization reaction with 
other alkynophilic metals such as silver
13
 and gold
14
 (table 9). Unfortunately, treating 
compound IV-16 with silver nitrate and refluxing the reaction in acetone for eleven days 
resulted in unreacted starting material. Similarly, treatment of compound IV-16 with 
auric acid and heating the reaction at 70 
o
C in ethanol for four days resulted in nothing 
more than the transesterification product. 
 
 
 
73 
 
                             
Trial Catalyst Solvent Temperature 
(
o
C) 
Time 
(days) 
Result 
1 AgNO3 acetone reflux 11 unreacted starting 
material 
2 HAuCl4 ethanol 70 4 transesterification 
product was 
isolated 
Table 9: Cyclization reaction attempts with AgNO3 and HAuCl4. 
In order to explain the difficulty we experienced with this reaction, we turned to 
Baldwin’s “Rules for Ring Closure”.15 Baldwin stated that favored ring closures are 
expected “when the length and nature of linking chain enables the terminal atoms to 
achieve the required trajectories” for the final ring bond formation.15 In contrast, 
disfavored reactions require severe distortion in order to reach the optimal trajectories.
15
 
The problematic cyclization step in the formation of the desired tricyclic adenine is 
hypothesized to proceed via a 6-endo-dig cyclization. However, the difficulty we 
experienced with this cyclization suggests that the 7-deazaadenine scaffold does not 
allow the interacting atoms to achieve the required trajectories for the final ring bond 
formation to occur. Perhaps severe distortion of the substrate is required to reach these 
optimal trajectories and this ultimately leads to a disfavored reaction. However, the 
problem with this hypothesis is that Baldwin’s rules are based on molecules with 
relatively low activation barriers, i.e. more flexible linkers. In our case, the 7-
deazaadenine scaffold is quite rigid, thus Baldwin’s rules may not be ideal for explaining 
the lack of reactivity we are experiencing with the 7-deazaadenine substrate. 
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Transition metal catalysis has become a very useful tool in organic synthesis. It allows 
for new synthetic transformations which were not previously possible by “classical” 
organic reactions. The activation of alkynes by late transition metal species toward 
nucleophilic attack is well known in the literature.
16
 In more detail, alkynes possess two 
orthogonal π-orbitals which can react with electrophilic metal centres.17 In the interaction 
with a metal centre, both the π-orbital in the plane of metal co-ordination and the π-
orbital perpendicular to it are able to interact with the d-orbitals of the metal.
17
 This co-
ordination withdraws electron density from the alkyne, thus making it more electrophilic 
and more susceptible to nucleophilic attack.
17
 For example, X-ray crystallographic 
studies on Cu(1)-alkyne complexes revealed that the π-electrons of the alkyne are 
strongly involved in the Cu(1) coordination, rendering the secondary carbon with a large 
partial positive charge.
18
 Thus, we hypothesize that the alkyne in our 7-deazaadenine 
substrate is being activated by the metal, however the exocyclic amino group is too far 
away to attack the activated alkyne. 
In order to gain some insight into the distance between the nucleophile and electrophile, 
the equilibrium geometries for the 7-deazaadenine and cytidine substrates were studied 
computationally using DFT methods (B3LYP/6-31+G**) implemented by Spartan14 
(Figure 19). The distance between the exocyclic nitrogen and the alkyne carbon in the 7-
deazaadenine substrate was calculated to be 3.84 Å, whereas the distance between the 
exocyclic nitrogen and the alkyne carbon in the cytidine substrate was calculated to be 
3.64 Å. Therefore, the nucleophile and electrophile are 0.2 Å further apart in the 7-
deazaadenine substrate than in the cytidine substrate. This difference of 0.2 Å may be the 
reason behind the difficulty we experienced in cyclizing the 7-deazaadenine substrate. 
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Figure 19: Equilibrium geometries of 7-deazaadenine and cytidine analog substrates 
for cyclization. 
In addition, this type of reaction has not, to our knowledge been reported. However, an 
example of a slightly different system with similar atom spacing has been described
19
 
(Scheme 15). 
 
Scheme 15: Intramolecular carboalkoxylation catalyzed by PtCl2. 
Although the functional groups of the benzoic acid ester starting material in Scheme 15 
are different than our 7-deazaadenine substrate, the PtCl2 catalyzed intramolecular 
cyclization may be an avenue worth exploring as a final attempt toward the tricyclic 
adenine analog.  
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4.3 Conclusion 
The synthesis towards a novel tricyclic adenine analog was attempted by extending the 
substrate scope of the Sonogashira cross-coupling/heteroannulation chemistry developed 
in the Hudson group
 
for cytidine analogs to adenine analogs. However, it was found that 
unlike the cytidine scaffold, the 7-deazaadenine substrate did not cyclize under the 
Sonogashira cross-coupling/heteroannulation reaction conditions to give a tricyclic 
adenine and the straight cross-coupled product was obtained in moderate yield. Efforts 
toward troubleshooting the Sonogashira/cyclization reaction on the 7-deazaadenine 
scaffold included carrying out the reaction at higher temperatures, attempting the 
cyclization reaction with greater equivalents of CuI and carrying out the cyclization 
reaction in the presence of other alkynophilic metals such as silver and gold. 
Unfortunately neither of these attempts produced the desired tricyclic adenine analog. 
DFT calculations revealed that the nucleophile and electrophile are 0.2 Å further apart in 
the 7-deazaadenine substrate than in the cytidine substrate. Based on the efficient 
activation of alkynes by late transition metal species toward nucleophilic attack, we 
postulate that the exocyclic amino group in our 7-deazaadenine substrate is too far away 
to attack the activated alkyne. 
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4.4 Future Work 
For some time now, we have been interested in the post synthetic modification of PNA 
with fluorescent alkynes using the Sonogashira reaction (Scheme 16), to construct novel 
fluorescent PNAs and evaluate their potential for use as fluorescent probes. However, 
carrying out the on-resin Sonogashira reaction on the cytidine scaffold is problematic due 
to the propensity of the substrate toward cyclization. Characterization of the PNA will 
also be difficult since the molecular mass of the cyclized product and the uncyclized 
product is the same. In contrast, the 7-deazaadenine substrate is superior to the cytidine 
substrate for performing the on-resin Sonogashira reaction, since we established that the 
7-deazaadenine substrate substituted at the 7-position with phenylacetylene does not 
undergo cyclization. Thus, using the 7-deazaadenine substrate for the on-resin 
Sonogashira reaction eliminates the uncertainty associated with whether or not the 
substrate has cyclized. 
 
Scheme 16: Post synthetic modification of PNA with fluorescent alkynes via the 
Sonogashira reaction 
There are many advantages associated with the post synthetic modification strategy. For 
instance, the number of synthetic steps as well as the amount of reagents required for the 
Sonogashira reaction is reduced. Moreover, upon successful incorporation of an 
appropriate PNA monomer into a PNA oligomer, the resin may be divided into portions 
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of three, for example, and the Sonogashira reaction can be carried out with three different 
fluorescent alkynes, thus giving rise to three novel fluorescent PNAs. The photophysical 
properties of these novel PNAs can then be evaluated for use as potential fluorescent 
probes to study nucleic acids. 
 
4.5 Experimental 
5-iodopyrimidine-4,6-diamine (IV-7): 
                                                       
4,6-Diaminopyrimidine hemisulfate monohydrate (3.8 g, 21.45 mmol) and K2CO3 (4.45 
g, 32.2 mmol) were suspended in 58 mL of water followed by the addition of iodine (6.0 
g, 23.6 mmol) and 14.5 mL of DMF. The solution was stirred at 45 
o
C
 
for 24 hours. After 
cooling, a 2 M solution of Na2S2O3 was added until the solution turned clear. The off-
white solid was then collected by vacuum filtration and washed with water (3 x 10 mL). 
The product was dried under high vacuum to give compound IV-7 in 81.3 % yield. 
1
H-
NMR (DMSO-d6, 400 MHz): δ 7.71 (s, 1H), 6.32 (bs, 4H). 
13
C-NMR (DMSO-d6, 400 
MHz): δ 162.9, 157.1, 55.3. HRMS (EI): calcd. For C4H5IN4 [M]
+
 235.9559, found 
235.9549. 
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5-((trimethylsilyl)ethynyl)pyrimidine-4,6-diamine (IV-8):  
                                                      
A 200 mL round bottom flask was charged with compound IV-7 (1.0 g, 4.24 mmol), 
(Ph3P)2PdCl2 (89.3 mg, 0.127 mmol) and CuI (146.6 mg, 0.77 mmol) was evacuated and 
backfilled with nitrogen. Anhydrous DMF (40 mL) was then added to the reaction 
mixture followed by the addition of TMS-acetylene (1.2 mL, 8.48 mmol) and 
triethylamine (0.65 mL, 5.05 mmol) via syringe, under nitrogen. The reaction was heated 
at 60 
o
C
 
for 2 hours. The solvent was removed in vacuo and the residue diluted with 120 
mL of EtOAc. The organic layer was washed with 3 % EDTA solution (3 x 30 mL) and 
brine (3 x 30 mL). The organic layer was dried and concentrated in vacuo. The crude 
product was purified by FCC eluting with EtOAc:MeOH 100:0 to 85:15 to afford 
compound IV-8 in 45 % yield. 
1
H-NMR (DMSO-d6, 400 MHz): δ 7.83 (s, 1H), 6.41 (bs, 
4H), 0.23 (s, 9H). 
13
C-NMR (DMSO-d6, 400 MHz): δ 163.6, 156.5, 105.1, 97.3, 36.7, 
0.1. HRMS (EI): calcd. For C9H14N4Si[M]
+
 206.0988, found 206.0989. 
7H-pyrrolo[2,3-d]pyrimidin-4-amine (IV-9): 
                                                                    
To a suspension of compound IV-8 (150 mg, 0.73 mmol) in NMP (1.4 mL), was added a 
suspension of t-BuOK (105.5 mg, 0.94 mmol), in NMP (4.2 mL) drop wise at 90 
o
C. The 
reaction mixture was stirred for 4 hours at 90 
o
C. After being cooled to room temperature 
the reaction mixture was neutralized with 1 M HCl and the remaining solvent was 
removed by vacuum distillation. The residue was purified via FCC eluting with 
CHCl3:MeOH 100:0 to 85:15 to give compound IV-9 in 86 % yield. 
1
H-NMR (DMSO-
d6, 400 MHz): δ 11.44 (bs, 1H), 8.01 (s, 1H), 7.05 (s, 1H), 6.87 (bs, 2H), 6.49 (s, 1H). 
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13
C-NMR (DMSO-d6, 400 MHz): δ 157.4, 151.6, 150.7, 120.8, 102.2, 98.9. HRMS (EI): 
calcd. For C6H6N4[M]
+
 134.0592, found 134.0589. 
5-iodo-7H-pyrrolo[2,3-d]pyrimidin-4-amine (IV-10): 
                                                                       
Compound IV-9 (150 mg, 1.12 mmol) was dissolved in 9.4 mL of DMF followed by the 
addition of NIS (290.7 mg, 1.12 mmol). The reaction was stirred in the dark, at room 
temperature overnight. Excess DMF was removed by rotary evaporation and the crude 
product was co-evaporated with toluene to remove trace amounts of DMF. The crude 
product was purified via FCC eluting with 5 % MeOH in CH2Cl2 to afford the iodinated 
compound IV-10 in 40 % yield. 
1
H-NMR ( DMSO-d6, 400 MHz): δ 12.07 (bs, 1H), 8.09 
(s, 1H), 7.39 (s, 1H), 6.69 (bs, 2H). 
13
C-NMR (DMSO-d6, 400 MHz): δ 156.4, 150.9, 
150.3, 127.1, 102.5, 50.4. HRMS (EI): calcd. For C6H5IN4[M]
+
 259.9559, found 
259.9549. 
Ethyl 2-(4-amino-5-iodo-7H-pyrrolo[2,3-d]pyrimidin-7-yl)acetate (IV-11): 
                                                                
Under an atmosphere of nitrogen, compound IV-10 (488 mg, 1.88 mmol) and NaH (60 % 
dispersion in mineral oil) (98 mg, 2.44 mmol) were suspended in 7.6 mL of DMF. The 
mixture was stirred for 30 minutes followed by the addition of ethyl bromoacetate. The 
reaction was left stirring for 24 hours. DMF was then removed by rotary evaporation and 
the crude product was purified via FCC eluting with EtOAc:Hexanes 50:50 to neat 
EtOAc to afford the desired compound IV-11 in 60 % yield. 
1
H-NMR (DMSO-d6, 600 
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MHz): δ 8.08 (s, 1H), 7.42 (s, 1H), 6.64 (bs, 2H), 4.97 (s, 2H), 4.14 (qt, J = 12 Hz, 2H), 
1.20 (t, J = 6 Hz, 3H). 
13
C-NMR (DMSO-d6, 400 MHz): δ 168.3, 157.1, 152.0, 150.0, 
130.2, 102.7, 61.1, 50.3, 45.1, 14.0. HRMS (EI): calcd. for C10H11IN4O2[M]
+
 345.9927, 
found 345.9924. 
Ethyl 2-(4-benzamido-5-iodo-7H-pyrrolo[2,3-d]pyrimidin-7-yl)acetate (IV-12):  
                                                          
Under an atmosphere of nitrogen, compound IV-11 (362 mg, 1.05 mmol), benzoic 
anhydride (950 mg, 4.2 mmol) and DMAP (13 mg, 0.105 mmol) were dissolved in 20 
mL of acetonitrile. The reaction mixture was heated to 70 
o
C and left stirring for 8 hours. 
Acetonitrile was then removed by rotary evaporation and the crude product was purified 
via FCC eluting with EtOAc:Hexanes 20:80 to EtOAc:Hexanes 80:20 to afford the 
desired compound IV-12 in 60 % yield. 
1
H-NMR ( DMSO-d6, 400 MHz): δ 10.87 (s, 
1H), 8.70 (s, 1H), 8.08 (d, J = 4Hz, 2H), 7.83 (s, 1H), 7.70 – 7.53 (m, 3H), 5.16 (s, 2H), 
4.18 (m, 2H), 1.23 (m, 3H). HRMS (EI): calcd. for C17H15IN4O3[M]
+
 450.0189, found 
450.0172. 
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Ethyl 2-(4-benzamido-5-(phenylethynyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)acetate 
(IV-13): 
                                                        
Compound IV-12 (50 mg, 0.11 mmol) was dissolved in dry, deoxygenated DMF (1 mL) 
to which CuI (4.2 mg, 0.02 mmol), Et3N (30 μL, 0.22 mmol), phenylacetylene (36 μL, 
0.33 mmol) and Pd(PPh3)4 (13 mg, 0.01 mmol) were sequentially added. The reaction 
mixture was stirred in the dark at 60 
o
C for 24 hours. The solvent was removed in vacuo 
and the residue diluted with 15 mL of EtOAc. The organic layer was washed with 3 % 
EDTA solution (3 x 5 mL) and brine (3 x 5 mL). The organic layer was dried and 
concentrated in vacuo. The crude product was purified by FCC eluting with 
EtOAc:hexanes 30:70 to 70:30 to afford compound IV-13 in 70 % yield. 
1
H-NMR 
(CDCl3, 400 MHz): δ 9.65 (bs, 1H), 8.83 (bs, 1H), 7.96 (m, 2H), 7.50 – 7.20 (m, 10 H), 
5.05 (s, 2H), 4.28 (q, J = 8 Hz, 2H), 1.31 (t, J = 8 Hz, 3H). 
13
C-NMR (CDCl3, 400 MHz): 
δ 167.4, 132.4, 131.8, 131.4, 128.9, 128.8, 128.5, 127.5, 122.1, 110.0, 92.8, 81.6, 62.2, 
45.5, 14.1. 
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4-chloro-7H-pyrrolo[2,3-d]pyrimidine (IV-14):  
                                                                 
7-deaza-6-hydroxy purine (4.0160 g, 29.7 mmol) was suspended in 45 mL of POCl3 and 
refluxed for 2 hours. The solution was cooled to room temperature and excess POCl3 was 
removed by rotary evaporation. A mixture of dichloromethane (600 mL) and ice water 
(200 mL) was then added to the dark-brown residue and stirred for 24 hours, or until the 
dark-brown residue was completely dissolved. The aqueous layer was then neutralized by 
adding increments of a saturated sodium bicarbonate solution (3 × 300 mL). The organic 
layer was collected, dried over MgSO4, and gravity filtered. The product was dried by 
rotary evaporation, producing a pale yellow solid (2.35 g, 52%). 
1
H-NMR ( DMSO-d6, 
400 MHz): δ = 12.57 (br s, 1H), 8.59 (s, 1H), 7.69 (d, J = 2.0 Hz, 1H), 6.61 (d, J = 2.0 
Hz, 1H); 
13
C-NMR (DMSO-d6, 400 MHz): δ = 151.7, 150.4, 150.3, 128.3, 116.5, 98.7. 
HRMS (EI): calcd. for C6H3ClN3[M]
+
 153.0094, found 153.0090. 
tert-butyl 2-(4-amino-5-iodo-7H-pyrrolo[2,3-d]pyrimidin-7-yl)acetate (IV-15): 
                                                           
Under an atmosphere of nitrogen, compound IV-10 (100 mg, 0.365 mmol) and NaH (60 
% dispersion in mineral oil) (19 mg, 0.475 mmol) were suspended in 1.6 mL of DMF. 
The mixture was stirred for 30 minutes followed by the addition of tert-butyl 
bromoacetate. The reaction was left stirring for 21 hours. DMF was then removed by 
rotary evaporation and the crude product was purified via FCC eluting with 
EtOAc:Hexanes 10:90 to EtOAc:Hexanes 90:10 to afford the desired compound IV-15 in 
65 % yield. 
1
H-NMR (DMSO-d6, 400 MHz): δ 8.08 (s, 1H), 7.42 (s, 1H), 6.64 (bs, 2H), 
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4.86 (s, 2H), 1.41 (s, 9H). 
13
C-NMR (DMSO-d6, 400 MHz): δ 167.3, 157.1, 151.9, 149.9, 
130.3, 102.7, 81.7, 50.0, 45.7, 27.6. 
tert-butyl 2-(4-amino-5-(phenylethynyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)acetate 
(IV-16): 
                                                            
Compound IV-15 (216.5 mg, 0.58 mmol) was dissolved in dry, deoxygenated DMF (4.1 
mL) to which CuI (22.1 mg, 0.12 mmol), Et3N (0.15 mL, 1.16 mmol), phenylacetylene 
(0.19 mL, 1.74 mmol) and PdCl2(PPh3)2 (41 mg, 0.058 mmol) were sequentially added. 
The reaction mixture was stirred in the dark at 60 
o
C for 24 hours. The solvent was 
removed in vacuo and the residue diluted with 15 mL of EtOAc. The organic layer was 
washed with 3 % EDTA solution (3 x 5 mL) and brine (3 x 5 mL). The organic layer was 
dried and concentrated in vacuo. The crude product was purified by FCC eluting with 
EtOAc:hexanes 60:40 to afford compound IV-16 in 52 % yield. 
1
H-NMR (CDCl3, 600 
MHz): δ 8.34 (bs, 1H), 7.53 (s, 2H), 7.38 (s, 2H), 5.93 (bs, 2H), 4.89, (s, 2H), 1.51 (s, 
9H). 
13
C-NMR (CDCl3, 400 MHz): δ 166.9, 157.5, 153.0, 150.1, 131.2, 128.8, 128.5, 
128.4, 122.9, 102.9, 95.8, 91.6, 83.0, 82.5, 46.1, 28.0. 
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Chapter 5  
5 Synthesis and Study of Intrinsic Nucleobase Quenchers 
5.1 Introduction 
In 1996 Kramer and Tyagi reported their pioneering work on molecular beacons, which 
are probes that fluoresce upon hybridization to a target nucleic acid sequence.
1
 Molecular 
beacons are single stranded nucleic acid molecules that possess a stem and loop structure 
(Figure 20).
1
 In more detail, the loop region of the molecule is a probe sequence that is 
complementary to a predetermined sequence in a target nucleic acid. The stem portion of 
the molecule is formed by the annealing of two complementary arm sequences that are on 
either side of the probe sequence. A fluorescent moiety is attached to the end of one arm 
and a fluorescence quencher is attached to the end of the other arm. The stem region of 
the molecule keeps these two moieties in close proximity to each other, causing the 
emission from the fluorophore to be quenched by FRET. Upon hybridization with a target 
sequence, the probe forms a hybrid that is longer and more stable than the hybrid formed 
by the arm sequences. This conformational transformation forces the arm sequences apart 
and causes the fluorophore and quencher to become spatially resolved. Since the 
fluorophore and quencher are no longer in close proximity to each other, emission from 
the fluorophore is observed upon irradiation with UV light. Molecular beacons are highly 
specific, even a single base pair mismatch results in no hybridization to the target 
sequence and thus no emission from the fluorophore.
1
 To that end, molecular beacons are 
useful probes for the detection of single nucleotide polymorphisms (SNPs).
2
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Figure 20: Structure and principle of operation of molecular beacons. 
Traditionally, fluorescence quenchers are tethered to the end of an oligonucleotide strand 
because incorporating them in any other position will interfere with base pairing and thus 
decrease duplex stability.
1
 Moreover, in their seminal puplication on molecular beacons, 
Kramer and Tyagi suggest that the quenching efficiency can be increased by shortening 
the linkers to which the quencher and fluorophore are attached.
1
 Furthermore the authors 
hinted towards an optimized molecular beacon structure where the fluorophore and 
quencher are linked to nucleotides that are located within the arm sequences to reduce the 
effects of unraveling of the stem region.
1
  
In 2000, Seitz developed a novel stemless PNA molecular beacon to detect the 
hybridization event.
3
 The author exploited the fact that unhybridized PNA forms intra- or 
intermolecular associates of unknown structure due to base stacking.
4
 Moreover, he 
proposed that a fluorophore and quencher appended to the unhybridized PNA would be 
positioned in close proximity to each other. In analogy to the DNA-based molecular 
beacons reported by Kramer and Tyagi, emission from the fluorophore is quenched by 
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FRET. Hybridization with a complementary nucleic acid sequence should induce a 
structural rearrangement whereby the fluorophore and quencher are no longer in close 
proximity to each other and emission from the fluorophore is observed upon irradiation 
with UV light.  
The author synthesized PNA-11 (Figure 21), via fluorenylmethyloxycarbonyl (Fmoc)-
based solid-phase synthesis using benzhydyloxycarbonyl (Bhoc) and tert-
butyloxycarbonyl (Boc)-nucleobase protection. The on-resin labelling was accomplished 
by treating the deprotected PNA with DABCYL hydroxysuccinimide ester to attach the 
DABCYL group to the primary amino group of the N
6
-aminoalkyl modified adenine.
3
 
The EDANS group was attached to the thiol group of the cysteine via selective alkylation 
with 5-(2’-iodoacetamidoethyl)amino-naphthalene sulfonic acid (IEDANS).3 
 
 
Figure 21: Structure of PNA-11. 
Upon treatment with an unrelated DNA sequence containing six mismatches, there was 
no significant change in the emission spectrum of PNA-11.
3
 However, upon 
hybridization with a complementary DNA target, the emission of the EDANS group in 
PNA-11 was enhanced by a factor of 4.6 at 25 
o
C and 6.4 at 20 
o
C respectively.
3
 Thus, 
the author developed a novel stemless PNA molecular beacon for detection of the 
hybridization event. It should be highlighted that target-unrelated arm sequences were not 
required for maintaining the structural integrity of these probes.   
This chapter focuses on the synthesis, quenching studies and attempted oligomerization 
of a novel intrinsic fluorescence quencher, 5-(4-dimethylaminophenyl)azouridine which 
incorporates the key structural feature of the universal quencher DABCYL (Figure 22). 
The advantage of synthesizing a base pairing competent quencher is that it can be 
incorporated anywhere in an oligonucleotide strand and should not compromise duplex 
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stability. Moreover, since we can incorporate this intrinsic quencher into the stem region 
of molecular beacons, more accurate FRET measurements can be obtained compared to 
traditional molecular beacon constructs where the quencher is attached via a long linker.  
 
Figure 22: Azouridine analog capable of Watson/Crick base pairing. 
5.2 Results and Discussion 
Synthesis of 5-(4-dimethylamino-phenyl)azouridine began with an azo coupling reaction 
between 5-diazouracil
5
 and N,N-dimethylaniline in the presence of the Lewis acid  boron 
trifluoride diethyl etherate
6
 to afford compound V-1 in 30 % yield (Scheme 17).
 
Compound V-1 was then alkylated at N1 using potassium carbonate and t-
butylbromoacetate to obtain compound V-2 in 64 % yield.
7
 Ester V-2 was deprotected 
with TFA to afford the carboxcylic acid, compound V-3 in 80 % yield. Next, compound 
V-3 was coupled onto an Fmoc protected peptide nucleic acid (PNA) backbone using 
HBTU to yield compound V-4 in 43 % yield. Lastly compound V-4 was deprotected with 
TFA to yield compound V-5, a monomer suitable for incorporation into a PNA oligomer. 
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Scheme 17: Synthesis of azouridine analog. 
 Spectroscopic Properties of Compound V-2 5.2.1
Compound V-2 exhibits an absorption maximum at 453 nm in EtOH. The molar 
absorptivity of compound V-2 in EtOH at 453 nm was calculated to be 27500 M
-1
 cm
-1
. 
DABCYL exhibits an absorption maximum at 450 nm in EtOH. The molar absorptivity 
of DABCYL in EtOH at 450 nm is 32000 M
-1
 cm
-1
. Thus compound V-2 exhibits 
spectroscopic properties similar to DABCYL and gave us confidence that it will act as an 
intrinsic fluorescence quencher. 
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 Quenching Studies 5.2.2
In order to determine viable FRET pairs for use in molecular beacon constructs, 
fluorescence quenching experiments were performed between compound V-2 and the 
fluorophores phenylpyrrolocytidine (pC), and pyrene. These fluorophores were chosen 
because their emission spectra overlapped with the absorption spectrum of compound V-
2.      
Thus, a 1 μM solution of the fluorophore phenylpyrrolocytidine in EtOH was quenched 
with varying concentrations of the azouridine analog, compound V-2. Figure 23 clearly 
illustrates a decrease in fluorescence emission from the pC fluorophore with increasing 
concentrations of quencher. Similarly, a 1 μM solution of pyrene in EtOH was quenched 
with varying concentrations of azouridine analog V-2. Figure 24 also shows a decrease in 
fluorescence emission from the fluorophore with increasing concentrations of quencher. 
Stern-Volmer plots were constructed and the Stern-Volmer quenching constant, Ksv, was 
calculated for each fluorophore quencher pair. The Ksv value for the quenching of pC 
with compound V-2 was found to be approximately 16000 M
-1
 (Figure 25). The Ksv value 
for the quenching of pyrene with compound V-2 was found to be approximately 8600 M
-
1
(Figure 26). Fundamentally, the Ksv value indicates the sensitivity of a fluorophore to a 
quencher.
8
 Thus, our Ksv values suggest that pC is more sensitive to quenching from 
compound V-2 than pyrene. Moreover, the inverse of the Stern-Volmer quenching 
constant, Ksv
-1
, is the concentration of the quencher at which 50 % of the intensity of the 
fluorophore is quenched. The Ksv
-1
 value for the quenching of pC with compound V-2 
was determined to be 6.25 x 10
-5
 M. The Ksv
-1
 value for the quenching of pyrene with 
compound V-2 was determined to be 1.16 x 10
-4
 M. These values suggest that pC is 
quenched more efficiently by compound V-2 than pyrene, since less concentration of the 
quencher is necessary to obtain the same amount of quenching. Thus compound V-2 and 
pC act as a better FRET pair than compound V-2 and pyrene.  
Lastly, Ksv is the product of the bimolecular quenching constant, kq, and the unquenched 
fluorescence lifetime, τo. Thus, a kq value for the quenching of pyrene with compound V-
2 was calculated from the Ksv value, 8600 M
-1
, and the unquenched fluorescence lifetime 
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of pyrene, 410 x 10
-9
 seconds.
9
 The kq value for the quenching of pyrene with compound 
V-2 was calculated to be approximately 2.10 x 10
10
 M
-1
s
-1
. Unfortunately, since the 
fluorescence lifetime of pC is not known, a kq value for the quenching of pC with 
compound V-2 was not calculated.   
Figure 23: Quenching spectra of pC with azouridine analog V-2. 
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Figure 24: Quenching spectra of pyrene with azouridine analog V-2. 
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Figure 25: Stern-Volmer plot for the quenching of pC in EtOH by compound V-2. 
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Figure 26: Stern-Volmer plot for the quenching of pyrene in EtOH by V-2.  
 Efforts Toward PNA Oligomerization 5.2.3
Initially we set out to synthesize the stemless PNA molecular beacon C-terminus-Lys-
pC-TTA-TTA-TTA-TTU
azo
-Lys-N-terminus. The chemical structures of pC and U
azo
 are 
shown in Figure 27. PNA synthesis was attempted with the assistance of an automated 
synthesizer on the 5 μmol scale using manufacturer supplied cycles for 
fluorenylmethyloxycarbonyl (Fmoc)-based oligomerization with tert-butyloxycarbonyl 
(Boc)-nucleobase protection.
10
 Upon completion of the synthesis, the Fmoc protecting 
group was removed from the N-terminal lysine and the PNA was cleaved from the resin 
according to previously reported procedures.
11
 The crude PNA was then subjected to 
purification by reversed-phase HPLC. Unfortunately, the custom monomer, U
azo
, was not 
successfully incorporated into PNA-1 as shown from the HPLC chromatograms in Figure 
28. Moreover, the UV-visible spectrum of the peak with a retention time of 36 min in the 
HPLC chromatograms shows characteristic absorbances at 263.9 and 363.5 nm for the 
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nucleobases and pC fluorophore respectively, however it lacks the absorbance at 450 nm 
which is indicative of the azo moiety (figure 29).    
 
 
Figure 27: Chemical structures of PNA monomers pC and U
azo
.  
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Figure 28: HPLC chromatograms of PNA-1 at 260 nm (top), 360 nm (middle) and 
450 nm (bottom). 
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Figure 29: UV-visible spectrum of peak with 36 min retention time in HPLC 
chromatogram. 
Our results suggested that the amide coupling reaction of U
azo
 onto the PNA was the 
problematic step. Thus, we decided to synthesize a separate PNA sequence on the peptide 
synthesizer and attempt the coupling reaction of U
azo
 onto the PNA manually in order to 
troubleshoot the reaction. To that end, PNA-2 (C-terminus-Lys-pC-TGT-CAC-TTC-
CTT-Fmoc-N-terminus), was synthesized as described for PNA-1.
10
 A small amount of 
crude PNA-2, approximately 5 mg, was cleaved from the resin and analyzed by mass 
spectrometry; HR-MS (ESI) m/z: calcd. for C167H204N66O47: 3885.7; found: 3889.8 [M + 
H]
+
.   
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Initial attempts at troubleshooting the amide coupling involved carrying out the reaction 
using a 1:1 mixture of DMF/DMSO as the solvent system (Table 10, trial 1). Our 
rationale for using DMSO as a co-solvent was based on a report that DMSO is a powerful 
dissociating solvent which is used to mitigate the potential aggregation of peptides during 
solid-phase peptide synthesis.
12
 After allowing the reaction to proceed for 1.5 h, 5 mg of 
resin was taken and the PNA was cleaved from the resin according to previously reported 
procedures.
11
 The crude PNA was then analyzed by UPLC, UV-visible spectroscopy and 
mass spectrometry. Unfortunately, the custom monomer, U
azo
, was not successfully 
incorporated into PNA-2 as shown from the UPLC traces in Figure 30. Moreover, the 
UV-visible spectrum of the peak with a retention time of 3.7 min in the UPLC trace 
shows characteristic absorbances at 260 and 360 nm for the nucleobases and pC 
fluorophore respectively, however it lacks the absorbance at 450 nm which is indicative 
of the azo moiety (Figure 31). The reaction was also attempted in neat DMSO at room 
temperature and at 80 
o
C (table 10, trials 2 and 3). Similarly, analysis by UPLC, UV-
visible spectroscopy and mass spectrometry revealed that the coupling reaction was still 
not successful.   
 
trial solvent temperature time result 
1 DMF/DMSO rt 1.5 h U
azo
 not 
incorporated 
2 DMSO rt 1.5 h U
azo
 not 
incorporated 
3 DMSO 80 
o
C 1.5 h U
azo
 not 
incorporated 
 Table 10: Attempts at troubleshooting the U
azo
 coupling reaction. 
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Figure 30: UPLC chromatograms of PNA-2 at 450 nm (top), 360 nm (middle) and 
260 nm (bottom). 
 
Figure 31: UV-visible spectrum of peak with 3.6 min retention time in UPLC 
chromatogram. 
 
 
101 
 
Since the on-resin amide coupling reaction of the U
azo
 PNA monomer onto PNA-2 was 
problematic, it was thought that perhaps coupling the azo acetic acid derivative, 
compound V-3, onto PNA-2 would be more facile. Unfortunately, carrying out the 
coupling reaction between the resin-bound PNA-2 and compound V-3 using HATU, 
DIPEA and DMF as a solvent, at room temperature for 1.5 hours did not result in 
incorporation of compound V-3 (Table 11, trial 1). Similarly, allowing the coupling 
reaction to proceed for 24 hours while keeping all other reaction conditions constant also 
resulted in an unsuccessful reaction (Table 11, trial 2). Lastly, the coupling reaction was 
also attempted using microwave irradiation at 75 
o
C for 5 minutes,
13
 however compound 
V-3 was still not incorporated into PNA-2 (Table 11, trial 3).     
 
trial solvent temperature time result 
1 DMF rt 1.5 h V-3 not 
incorporated 
2 DMF rt 24 h V-3 not 
incorporated 
3 DMF MW, 75 
o
C 5 min V-3 not 
incorporated 
Table 11: Attempts at troubleshooting the coupling reaction between PNA-2 and 
compound V-3. 
The fact that we can couple compound V-3 to an Fmoc protected PNA backbone in 
solution (Scheme 17), suggests that the difficulty we are experiencing is due to the amide 
coupling reaction being carried out on the resin. Moreover, U
azo 
was successfully coupled 
with benzylamine in solution (Scheme 18). Thus, the problem seems to arise from the on-
resin nature of the reaction. 
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Scheme 18: Amide coupling between U
azo
 monomer and benzylamine in solution. 
Successful solid-phase peptide syntheses are often hampered by aggregation of the 
growing peptide chain due to secondary structure formation during synthesis, interchain 
or intrachain association via hydrogen bonding or hydrophobic interactions, and peptide-
polymer matrix association.
14
 This results in a hindered amino terminus which ultimately 
results in reduced coupling and deprotection efficiencies.
14
 Our rationale for choosing the 
cross-linked ethoxylate acrylate resin (CLEAR), was to mitigate any peptide-polymer 
matrix association.
15
 Moreover, our relatively low resin loading (0.05 mmol/g) should 
have ruled out the possibility of interchain aggregation.
14
 Initially, we hypothesized that 
perhaps intrachain aggregation via hydrogen bonding or hydrophobic interactions was 
responsible for the unsuccessful amide coupling reaction. However, when we attempted 
to couple U
azo
 onto the C-terminus of the PNA rather than the N-terminus, the reaction 
was still not successful. Thus, we can postulate that the difficulty we experienced with 
this reaction stems from a physical attraction of the U
azo
 monomer to the CLEAR resin, 
which ultimately hinders its ability to undergo the amide coupling. 
5.3 Conclusions 
An intrinsic nucleobase quencher was synthesized via the azo coupling reaction between 
5-diazouracil and N,N-dimethylaniline. The spectroscopic properties of this compound 
were found to be similar to those of the universal quencher DABCYL. In order to 
determine viable FRET pairs for use in molecular beacons, fluorescence quenching 
experiments were performed between compound V-2 and the fluorophores 
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phenylpyrrolocytidine (pC), and pyrene. Stern-Volmer plots were constructed and the 
Stern-Volmer quenching constant, Ksv, was calculated for each fluorophore quencher 
pair. The Ksv values suggest that pC is more sensitive to quenching from compound V-2 
than pyrene. Moreover, the inverse of the Stern-Volmer quenching constant, Ksv
-1
, was 
calculated for each fluorophore quencher pair. The Ksv
-1
 values suggest that pC is 
quenched more efficiently by compound V-2 than pyrene. Thus, compound V-2 and pC 
act as a better FRET pair than compound V-2 and pyrene. Lastly, The kq value for the 
quenching of pyrene with compound V-2 was calculated to be approximately 2.10 x 10
10
 
M
-1
s
-1
. Incorporation of the custom monomer U
azo
 into a PNA oligomer proved to be 
problematic. Our results suggested that the amide coupling reaction of U
azo
 onto the PNA 
was the problematic step. Unfortunately, various attempts at troubleshooting this reaction 
were not successful. We postulate that the problematic coupling reaction stems from a 
physical attraction between the U
azo
 monomer and the CLEAR resin.  
5.4 Future Work 
An alternate route to mitigate difficult on resin amide couplings involves carrying out the 
reaction in solution to form a dimer, followed by on-resin amide coupling of the dimer 
onto the PNA. Thus, we propose to synthesize a thymine-U
azo
 dimer (Scheme 19) and, 
upon deprotection of the allyl ester protecting group, attempt the incorporation of this 
dimer into a PNA oligomer. Upon successful incorporation of the thymine-U
azo
 dimer 
into a PNA oligomer, the photophysical properties of the PNA can be investigated for 
potential use as a stemless molecular beacon.    
 
Scheme 19: Proposed synthesis of a thymine-U
azo
 dimer.  
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5.5 Experimental 
5-((4-(dimethylamino)phenyl)diazenyl)pyrimidine-2,4(1H,3H)-dione (V-1): 
                                                         
To a cold solution of 5-aminouracil (3.00 g, 23.6 mmol) in 45 mL of 1 M HCl was added 
a solution of 6.9 % NaNO2 (26 mL) drop wise over 15 minutes. The reaction mixture was 
stirred for another 45 minutes on ice, filtered, washed with water and hexanes and dried 
under vacuum to give 5-diazouracil in 81 % yield, which was used in the next step 
without further purification.   5-diazouracil (3.00 g, 19.2 mmol) was suspended in 210 
mL of anhydrous acetonitrile. The reaction was purged with nitrogen for 5 minutes 
followed by the slow dropwise addition of borontrifluoride diethyl etherate (2.4 mL, 19.2 
mmol). The reaction was stirred for 20 minutes at room temperature followed by the 
addition of N,N-dimethylaniline (2.4 mL, 19.2 mmol). The reaction mixture was stirred at 
room temperature overnight and the crude product was collected by vacuum filtration. 
The crude product was triturated in 200 mL of boiling ethanol for 1.5 hours and filtered 
once again to afford compound V-1 in 30 % yield. Compound V-1 was used without 
further purification. 
1
H-NMR ( DMSO-d6, 400 MHz): δ 11.46 (s, 1H), 11.32 (s, 1H), 
7.72-7.66 (m, 1H), 7.65-7.59 (m, 2H), 6.83-6.75 (m, 2H), 3.03 (s, 6H). 
13
C-NMR 
(DMSO-d6, 400 MHz): δ 161.1, 152.1, 150.6, 142.8, 130.1, 128.8, 124.3, 111.5, 36.7. 
HRMS (EI): calcd. For C12H13N5O2 [M]
+
 259.1069, found 259.1061. 
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tert-butyl 2-(5-((4-(dimethylamino)phenyl)diazenyl)-2,4-dioxo-3,4-
dihydropyrimidin-1(2H)-yl)acetate (V-2): 
                                                            
Compound V-1 (500 mg, 1.93 mmol) and K2CO3 (270 mg, 1.95 mmol) were suspended 
in 8 mL of anhydrous DMF followed by the addition of tert-butyl-2-bromoacetate (0.28 
mL, 1.93 mmol). The reaction was left stirring at room temperature overnight under an 
atmosphere of nitrogen. The solvent was removed under reduced pressure and the crude 
product was dissolved in dichloromethane (50 mL) and washed with saturated NaHCO3 ( 
2 x 25 mL), water ( 2 x 25 mL) and brine ( 2 x 25 mL). The organic phase was collected 
and dried over anhydrous sodium sulfate, filtered and concentrated under reduced 
pressure. The crude product was purified via FCC eluting with EtOAc:hexanes 10:90 to 
EtOAc:hexanes 90:10, to afford compound V-2 in 64 % yield. 
1
H-NMR (DMSO-d6, 600 
MHz): δ 11.78 (s, 1H), 8.07 (s, 1H), 7.66 (d, J = 6 Hz, 2H), 6.81 (d, J = 12 Hz, 2H), 4.54 
(s, 2H), 3.05 (s, 6H), 1.43 (s, 9H). 
13
C-NMR (DMSO-d6, 400 MHz): δ 167.0, 160.8, 
152.2, 150.2, 142.8, 133.9, 128.9, 124.4, 111.5, 81.9, 49.8, 36.7, 27.7. HRMS (EI): calcd. 
For C18H23N5O4 [M]
+
 373.1750, found 373.1748. 
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2-(5-((4-(dimethylamino)phenyl)diazenyl)-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-
yl)acetic acid (V-3): 
                                                   
Compound V-2 (150 mg, 0.40 mmol) was dissolved in 4 mL of anhydrous CH2Cl2 and 
cooled to 0 
o
C followed by the addition of 2 mL of TFA. The reaction was stirred for 10 
minutes on ice and a further 3 hours at room temperature. The solvent was then removed 
by nitrogen stream to give the TFA salt of compound V-3 in quantitative yield. 
Compound V-3 was used without further purification. 
1
H-NMR ( DMSO-d6, 600 MHz): 
δ 11.74 (s, 1H), 8.05 (s, 1H), 7.65 (d, J = 12 Hz, 2H), 6.81 (d, J = 12 Hz, 2H), 4.56 (s, 
2H), 3.04 (s, 6H). 
13
C-NMR (DMSO-d6, 400 MHz): δ 169.8, 160.9, 152.2, 150.4, 142.9, 
134.3, 128.8, 124.4, 111.6, 49.6, 36.6. HRMS (EI): calcd. For C14H15N5O4 [M]
+
 
317.1124, found 317.1125.  
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(E)-tert-butyl 2-(N-(2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)ethyl)-2-(5-((4-
(dimethylamino)phenyl)diazenyl)-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-
yl)acetamido)acetate (V-4): 
                                          
Compound V-3 (150 mg, 0.47 mmol) was dissolved in 3 mL of anhydrous DMF and 
cooled to 0 
o
C followed by the addition of a solution of N-[2-(Fmoc)aminoethyl]glycine-
t-butyl ester (178 mg, 0.45 mmol) in DMF (0.225 M), Hunig’s base (0.7 mL, 3.95 mmol), 
HOBt (61 mg, 0.45 mmol) and HBTU (171, 0.45 mmol). The reaction was warmed to 
room temperature and left stirring for 24 h under an atmosphere of nitrogen. The reaction 
mixture was diluted with 60 mL of EtOAc and washed with 0.1 M HCl (2 x 30 mL), 
water (2 x 30 mL) and brine (2 x 30 mL). The organic layer was collected, dried over 
sodium sulfate, filtered and concentrated under reduced pressure. The crude product was 
purified via FCC eluting with EtOAc:Hexanes 60:40 – 100:0 to afford compound V-4 in 
43 % yield. Compound V-4 exists in solution as a pair of slowly exchanging rotamers; 
signals attributed to major (ma.) and minor (min.) rotamers are designated. 
1
H-NMR ( 
DMSO-d6, 400 MHz): δ 11.76 (s, ma., 0.60H), 11.75 (s, min., 0.40H), 8.00 – 6.70 (m, 14 
H), 4.86 (s, ma., 1.25H), 4.67 (s, min., 0.81 H), 4.35 (s, min., 0.69 H), 3.95 (s, ma., 1.27 
H), 4.34-4.15 (m, 3H), 3.44-3.39 (m, 2H), 3.31-3.24 (m, 2H), 3.15-3.10 (m, 1H), 3.03 (s, 
6 H), 1.47 (s, min., 3H), 1.39 (s, ma. 6H). 
13
C-NMR (DMSO-d6, 400 MHz): δ 167.9, 
167.0, 160.8, 156.3, 152.1, 150.2, 143.8, 142.8, 140.7, 128.7, 127.6, 127.0, 125.1, 124.3, 
120.1, 111.5, 105.2, 82.0, 80.9, 71.5, 65.5, 46.7, 36.2, 27.7, 24.3, 23.6, 20.7, 10.2. HRMS 
(EI): calcd. For C37H42N7O7 [MH]
+
 696.3146, found 696.3170. 
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(E)-2-(N-(2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)ethyl)-2-(5-((4-
(dimethylamino)phenyl)diazenyl)-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-
yl)acetamido)acetic acid (V-5): 
                                         
Compound V-4 (125 mg, 0.18 mmol) was dissolved in 5 mL of CH2Cl2 and cooled to 0 
o
C followed by the slow drop wise addition of TFA (2.5 mL). The reaction was stirred for 
4 hours at room temperature. The reaction was evaporated to dryness via nitrogen stream 
and the remaining volatiles were removed by coevaporation with CH2Cl2 and diethyl 
ether. The product was dried under vacuum to afford the TFA salt of compound V-5 in 
80 % yield. Compound V-5 exists in solution as a pair of slowly exchanging rotamers; 
signals attributed to major (ma.) and minor (min.) rotamers are designated.  
1
H-NMR ( 
DMSO-d6, 600 MHz): δ 11.74 (s, ma., 0.60H), 11.73 (s, min., 0.40H), 8.00 – 6.70 (m, 14 
H), 4.87 (s, ma., 1.20H), 4.69 (s, min., 0.80H), 4.35 (s, min., 0.80H), 4.00 (s, ma., 1.20H, 
), 4.34-4.15 (m, 4H), 3.45-3.32 (m, 2H), 3.31-3.09 (m, 2H), 3.03 (s, 6 H). 
13
C-NMR 
(DMSO-d6, 400 MHz): δ 170.7, 170.4, 167.4, 167.0, 160.8, 158.1, 157.7, 156.3, 152.1, 
150.2, 144.8, 143.9, 142.9, 140.7, 134.3, 128.8, 127.6, 127.1, 125.1, 124.3, 120.1, 111.6, 
65.5, 46.7. HRMS (EI): calcd. For C33H34N7O7 [MH]
+
 640.2520, found 640.2520. 
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6 Overall Conclusion and Outlook 
This thesis focused on nucleobase modified PNA and DNA to expand the repertoire of 
available nucleobase analogs used in the study of nucleic acids. Although there are many  
fluorescent nucleobase analogs to choose from, the search for an ideal analog with 
optimal photophysical characteristics, i.e., high fluorescence quantum yield, red-shifted 
absorption maxima, not destabilizing to hybridization, ability to provide nucleobase 
discrimination, and the ability to report differences in the local environment through a 
change in fluorescence intensity or emission wavelength is still underway.  
Chapter 2 described the synthesis of an acridine labelled nucleobase for the purpose of 
investigating its potential as a base-discriminating fluorophore. The literature shows us 
that the development of fluorescent uridine analogs has been extensively investigated, 
due to it offering the simplest chemistry relative to the other nucleobases. However, the 
derivatization of 5-aminouracil with chromophoric molecules is an area of research that 
remains relatively unexplored. Upon successful incorporation of the acridine labelled 
monomer into a PNA oligomer, thermal denaturation studies of DNA complexes with 
this oligomer illustrated its ability to discriminate between a fully matched 
complementary strand and the corresponding mismatched strands. Unfortunately, the 
fluorescence of the PNA oligomer could not be used to study hybridization because the 5-
(acridin-9-ylamino)uracil modification was thermally labile in aqueous solution and 
liberated the highly fluorescent acridone moiety, thus obscuring the signal from the PNA. 
Despite not being an effective BDF, the ease at which the modification was introduced 
indicates the potential of this chemical route for the introduction of chemically modified 
nucleobases into PNA.  
The literature also shows us that certain fluorescent nucleobase analogs are 
underrepresented, especially analogs of adenine and guanine. To that end, this thesis 
focused on the synthesis of novel fluorescent 7-deazaadenosine analogs and chemistry 
toward a novel tryciclic 7-deazaadenine analog. The 7-deazaadenosine analogs, A
pyr
, 
A
mon
 and A
phen
 were photophysically characterized in dioxane, EtOH, and H2O to 
evaluate their potential for use as environmentally sensitive fluorescent probes. All three 
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analogs displayed high solvatofluorochromicity in H2O, relative to their emission 
wavelengths in dioxane and EtOH. Moreover, all three analogs exhibited moderate to 
high fluorescence quantum yields in dioxane and EtOH, and significantly lower 
fluorescence quantum yields in H2O, indicating that these analogues display 
microenvironment sensitivity. Among them, A
pyr
 showed the most promise, due to it’s 
red-shifted absorption and emission wavelengths, large molar extinction coefficients, 
high fluorescence quantum yields in dioxane (ΦF = 0.52) and EtOH (ΦF = 0.43), and 
dramatic decrease in fluorescence quantum yield in H2O (ΦF = 0.01). These 
characteristics, in conjunction with the benefit that large substituents at the 7-position of 
the 7-deazapurine can be accommodated in the major groove of resultant duplexes, 
suggest that A
pyr
 has considerable potential for use as an environmentally sensitive 
fluorescent probe and warrants further study in the context of a DNA oligonucleotide.  
Unfortunately the tricyclic 7-deazaadenine analog was not accessed. However, the 
synthesis and photophysical evaluation of novel fluorescent 7-deazaadeine analogs 
substituted at the 7-position with various fluorescent alkynes is an area of research that is 
yet to be explored in the context of PNA. The chemistry described in Chapter 4 paves the 
way for the derivatization of the 7-deazaadenine scaffold with fluorescent alkynes via the 
Sonogashira reaction. Moreover, the 7-deazaadenine substrate may be useful in the post 
synthetic modification of PNA with fluorescent alkynes via an on-resin Sonogashira 
reaction, for the construction of novel fluorescent PNAs which may be used to study 
nucleic acids.  
Lastly, Chapter 5 focused on the synthesis of an intrinsic nucleobase quencher to 
overcome some of the limitations associated with traditional molecular beacons. PNA 
monomer U
azo
 was synthesized in 5 steps starting from 5-diazouracil. In order to 
determine viable FRET pairs, fluorescence quenching experiments were performed 
between compound V-2 and the fluorophores phenylpyrrolocytidine (pC), and pyrene. 
Stern-Volmer plots were constructed and the Stern-Volmer quenching constant, Ksv, was 
calculated for each fluorophore quencher pair. The Ksv values suggest that pC is more 
sensitive to quenching from compound V-2 than pyrene. Moreover, the inverse of the 
Stern-Volmer quenching constant, Ksv
-1
, was calculated for each fluorophore quencher 
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pair. The Ksv
-1
 values suggest that pC is quenched more efficiently by compound V-2 
than pyrene. Thus, compound V-2 and pC act as a better FRET pair than compound V-2 
and pyrene. Although incorporation of the custom monomer U
azo
 into a PNA oligomer 
proved to be problematic, this work represents a step forward toward the construction of 
novel stemless PNA molecular beacons which may be used to detect nucleic acids.   
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Appendices 
Appendix 1: General experimental procedures. 
 
Reagents were commercially available and all solvents were HPLC grade except for 
water (18.2 M Ω cm millipore water) and DMF (dried over Al2O3, in a solvent 
purification system).  Solvents were removed under reduced pressure in a rotary 
evaporator, aqueous solutions were lyophilised and organic extracts were dried over 
Na2SO4.  Flash column chromatography (FCC) was carried out using silica gel (SiO2), 
mesh size 230 - 400 Å. Thin-layer chromatography (TLC) was carried out on Al backed 
silica gel plate with compounds visualised by UV light.  NMR spectra were recorded at 
room temperature on a 400 or 600 MHz spectrometer for 
1
H NMR spectra δ values were 
recorded as follows: CDCl3 (7.27 ppm); DMSO-D6 (2.49 ppm); for 
13
C (400 MHz) δ 
CDCl3 (77.0 ppm); DMSO-D6 (39.5 ppm).  Mass spectra (MS) were obtained using 
electron impact (EI), or electrospray ionisation (ESI). 
 
Appendix 2: Temperature dependent UV melting studies 
 
Hybridization and UV melting experiments were carried out in aqueous buffer: 100 
mmol/L NaCl, 10 mmol/L Na2HPO4, and 0.1 mmol/L EDTA at pH 7. UV melting 
experiments were performed on a CARY UV-visible spectrophotometer. UV melting 
experiments were carried out at 2 μmol/L strand concentration. Samples were heated to 
90 
o
C, cooled to room temperature over 3 hours and placed at 10 
o
C overnight. 
Denaturation was performed from 10 
o
C to 90 
o
C at a scan rate of 0.5 
o
C/min. The Tm 
values are an average of three measurements and are rounded to the nearest 0.5 
o
C. The 
error in Tm values was +/- 1 
o
C. The Tm values were extracted from the melt curves using 
the first derivative method. 
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Appendix 3: Methods of photophysical analysis 
 
In order to determine the photophysical parameters of A
pyr
, A
mon
, and A
phen
 in the various 
solvents of interest, spectroscopic grade EtOH, spectroscopic grade dioxane, and H2O 
(18.2 M Ω cm millipore water) were used for analysis. The samples were analyzed using 
a 1cm wide four-sided Quartz cuvette for all photophysical analyses. Thus, a light path 
length (ℓ) of 1 cm was used for all absorption experiments. All absorption experiments 
were carried out using a CARY UV-Visible spectrophotometer and all fluorescence 
experiments were carried out using a PTI fluorimeter.     
The molar extinction coefficients (ε) of Apyr, Amon, and Aphen in EtOH, dioxane, and H2O 
were calculated using Beer-Lambert’s law (A = ε c ℓ). For each set of analog and solvent, 
five different solutions of known concentration were prepared by dissolving ~0.0010 g of 
the analogs with 5 mL of solvent, in order to create a stock solution. Then, 50 μL, 100 
μL, 150 μL, 200 μL, and 250 μL samples of the stock solution were further diluted with 
10 mL of solvent. The resulting samples were then analyzed at the analog’s λabmax using 
UV-Vis absorption spectroscopy, in order to generate a plot of sample absorbance (A) 
against sample concentration (c). The molar extinction coefficient was then determined as 
the slope of the resulting plot, using a constant light path length (ℓ) of 1 cm. In addition, 
the error for the molar extinction coefficients were calculated based on a 95% confidence 
interval. Due to insufficient solubility of A
pyr
, A
mon
, and A
phen
 in water, they were first 
dissolved in 0.20 mL of spectroscopic grade DMSO, prior to dilution with water. 
However, considering the magnitude of dilution, the final concentration of DMSO in the 
analyzed samples is considered to be negligible.  
 
The fluorescence quantum yield (ΦF) for A
pyr
, A
mon
, and A
phen
 in EtOH, dioxane, and 
H2O were calculated. In order to determine the fluorescence quantum yield of an analog, 
a fluorescence standard that absorbs distinctively at the wavelength of interest must be 
chosen for co-analysis. For each set of analog and solvent, five solutions of different 
concentrations were prepared for both the analogue and it’s corresponding fluorescence 
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standard. The solutions were then analyzed by UV-Vis absorption spectroscopy, in order 
to determine the absorbance of each solution at the wavelength of interest. The samples 
used for analysis were diluted such that their absorbance was below 0.1, in order to 
minimize re-absorption effects. For this experiment, the wavelength of interest was the 
wavelength of maximum absorption for each analogue in the corresponding solvent. The 
samples were then excited at the wavelength of interest and the resulting fluorescence 
was measured using a PTI fluorimeter. The integrated fluorescence intensity was then 
plotted against the absorbance for each sample, for both the analog and its corresponding 
fluorescence standard. The slopes of these two plots were then used in conjunction with 
the known fluorescence quantum yield of the fluorescence standard (ΦSTD), in order to 
determine the fluorescence quantum yield of the compound of interest. These calculations 
are based on the following equation: 
Φ𝐹 =  Φ𝑆𝑇𝐷  (
𝑆𝑙𝑜𝑝𝑒𝐹
𝑆𝑙𝑜𝑝𝑒𝑆𝑇𝐷
) (
𝜂𝐹
2
𝜂𝑆𝑇𝐷
2 ) 
 
In order to determine the fluorescence quantum yields of A
pyr
, A
mon
, and A
phen
, the 
fluorescence standard’s fluorescence quantum yield in the solvent of interest must be 
known. However, there were no established fluorescence quantum yields in the literature 
for some of the fluorescent standards in the solvents of interest. Thus, the fluorescence 
quantum yields of these standards were calculated manually, relative to a known 
fluorescence quantum yield of the same standard in a different solvent. This was done 
using the same procedure as for determining the fluorescence quantum yields of A
pyr
, 
A
mon
, and A
phen
. The difference in solvent was accounted for by including a ratio of the 
refractive indices in the calculation, as seen in the above equation. The fluorescence 
quantum yields that were used for analysis are presented in Table 12.  
Due to the low solubility of A
pyr
, A
mon
, and A
phen
 in H2O, they were first dissolved in 0.20 
mL of spectroscopic grade DMSO, prior to dilution with H2O. However, considering the 
magnitude of dilution, the final concentration of DMSO in the analyzed samples is 
considered to be negligible. Similarly, due to insufficient solubility of quinine sulfate in 
H2O, quinine sulfate in 0.5 M H2SO4 was used as the fluorescent standard for the 
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determination of the quantum yields of A
pyr
, A
mon
, and A
phen
 in H2O. However, due to the 
low concentration of H2SO4 in the quinine sulfate samples analyzed, the effect of H2SO4 
on the quantum yield is considered to be negligible.  
 
 
 
Nucleoside Solvent Fluorescence Standard Lit. ΦF 
12 
Calcd. ΦF  
 EtOH 9,10-Diphenylanthracene 0.95
 
 
A
pyr
 H2O Quinine Sulfate 0.55  
 Dioxane 9,10-Diphenylanthracene  0.83 
 EtOH Pyrene 0.65  
A
mon
 H2O Quinine Sulfate 0.55  
 Dioxane Pyrene  0.87 
 EtOH Pyrene 0.65  
A
phen
 H2O Quinine Sulfate 0.55  
 Dioxane Pyrene  0.87 
Table 12: Fluorescence standards and their corresponding quantum yields. 
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Appendix 4: Fluorescence quenching studies 
The fluorescence quenching studies were performed on a PTI fluorimeter. A 1 μM 
solution of pC was irradiated at 343 nm and the emission spectrum was obtained in the 
absence of quencher. Next compound V-2 was added to the 1 μM solution of pC in 6 μL 
increments and the emission spectra were obtained to determine the amount of 
quenching. The UV-visible spectrum of each sample was obtained before and after the 
addition of quencher. The total concentration of quencher after each addition was 
determined and a Stern-Volmer plot was constructed to analyze the FRET pair.  
Similarly, a 1 μM solution of pyrene was irradiated at 336 nm and the emission spectrum 
was obtained in the absence of quencher. Compound V-2 was then added to the 1 μM 
solution of pyrene in 6 μL increments and the emission spectra were obtained to 
determine the amount of quenching. The UV-visible spectrum of each sample was 
obtained before and after the addition of quencher. The total concentration of quencher 
after each addition was determined and a Stern-Volmer plot was constructed to analyze 
the FRET pair. 
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Appendix 5: 
1
H-NMR spectrum of compound II-1. 
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Appendix 6: 
13
C-NMR spectrum of compound II-1. 
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Appendix 7: 
1
H-NMR spectrum of compound II-2. 
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Appendix 8: 
13
C-NMR spectrum of compound II-2. 
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Appendix 9:
 1
H-NMR spectrum of compound II-3. 
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Appendix 10: 
13
C-NMR spectrum of compound II-3. 
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Appendix 11:
 1
H-NMR spectrum of compound II-4. 
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Appendix 12: 
13
C-NMR spectrum of compound II-4. 
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Appendix 13:
 1
H-NMR spectrum of compound II-5. 
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Appendix 14: 
13
C-NMR spectrum of compound II-5. 
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Appendix 15:
 1
H-NMR spectrum of compound III-17. 
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Appendix 16: 
13
C-NMR spectrum of compound III-17. 
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Appendix 17:
 1
H-NMR spectrum of compound III-18. 
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Appendix 18: 
13
C-NMR spectrum of compound III-18. 
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Appendix 19:
 1
H-NMR spectrum of compound III-19. 
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Appendix 20: 
13
C-NMR spectrum of compound III-19. 
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Appendix 21: 
1
H-NMR spectrum of compound III-20. 
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Appendix 22: 
13
C-NMR spectrum of compound III-20. 
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Appendix 23: 
1
H-NMR spectrum of compound III-21. 
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Appendix 24: 
13
C-NMR spectrum of compound III-21. 
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Appendix 25: 
1
H-NMR spectrum of compound III-22. 
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Appendix 26: 
13
C-NMR spectrum of compound III-22. 
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Appendix 27: 
1
H-NMR spectrum of compound III-23. 
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Appendix 28: 
13
C-NMR spectrum of compound III-23. 
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Appendix 29: 
1
H-NMR spectrum of compound IV-7. 
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Appendix 30: 
13
C-NMR spectrum of compound IV-7. 
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Appendix 31: 
1
H-NMR spectrum of compound IV-8. 
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Appendix 32: 
13
C-NMR spectrum of compound IV-8. 
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Appendix 33: 
1
H-NMR spectrum of compound IV-9. 
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Appendix 34: 
13
C-NMR spectrum of compound IV-9. 
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Appendix 35: 
1
H-NMR spectrum of compound IV-10. 
PROTON_7iodo_7_deaza_A_01
14 13 12 11 10 9 8 7 6 5 4 3 2 1 0 -1 -2
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
2.041.001.001.07
Water
1
2
.0
7
8
.0
9
7
.3
9
6
.6
9
2
.5
6
2
.5
0
2
.5
0
 
 
 
 
 
 
 
 
 
 
149 
 
Appendix 36: 
13
C-NMR spectrum of compound IV-10. 
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Appendix 37: 
1
H-NMR spectrum of compound IV-11. 
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Appendix 38: 
13
C-NMR spectrum of compound IV-11. 
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Appendix 39: 
1
H-NMR spectrum of compound IV-12. 
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Appendix 40: 
1
H-NMR spectrum of compound IV-13. 
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Appendix 41: 
13
C-NMR spectrum of compound IV-13. 
CARBON_Somnogashira_100_degrees_C_carbon_01
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Appendix 42: 
1
H-NMR spectrum of compound IV-15. 
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Appendix 43: 
13
C-NMR spectrum of compound IV-15. 
CARBON_7DA_iodo_amino_tbutyl_ester_carbon_01
180 160 140 120 100 80 60 40 20 0
Chemical Shift (ppm)
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
1
6
7
.1
9
1
5
6
.9
5
1
5
1
.8
1
1
4
9
.8
3
1
3
0
.1
1
1
0
2
.5
3
8
1
.5
6
4
9
.8
8
4
5
.5
3
3
9
.7
9
3
9
.6
5
3
9
.5
1
3
9
.3
7
3
9
.2
3
3
9
.0
9
3
8
.9
5
2
7
.5
1
 
 
 
 
 
 
 
 
 
 
 
157 
 
Appendix 44: 
1
H-NMR spectrum of compound IV-16. 
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Appendix 45: 
13
C-NMR spectrum of compound IV-16. 
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Appendix 46: 
1
H-NMR spectrum of compound V-1. 
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Appendix 47: 
13
C-NMR spectrum of compound V-1. 
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Appendix 48: 
1
H-NMR spectrum of compound V-2. 
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Appendix 49: 
13
C-NMR spectrum of compound V-2. 
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Appendix 50: 
1
H-NMR spectrum of compound V-3. 
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Appendix 51: 
13
C-NMR spectrum of compound V-3. 
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Appendix 52: 
1
H-NMR spectrum of compound V-4. 
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Appendix 53: 
13
C-NMR spectrum of compound V-4. 
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Appendix 54: 
1
H-NMR spectrum of compound V-5. 
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Appendix 55: 
13
C-NMR spectrum of compound V-5. 
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Appendix 56: Sample calculation: determination of molar extinction coefficients for 
compound III-21 (A
pyr
) in EtOH at 366 nm (blue), dioxane at 367 nm (green) and 
H2O at 364 nm (red).  
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Appendix 57: Sample calculation: data for the calculation of ΦF for compound III-
21 (A
pyr
) in EtOH. A plot of the integrated fluorescence intensity at different 
absorbance values for 9,10-diphenylanthracene (blue) and compound III-21 (red). 
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